Brigham Young University

BYU ScholarsArchive
Theses and Dissertations
2006-12-01

Development of Methods for the Study of Phosphoproteins
Zhaoyuan Chen
Brigham Young University - Provo

Follow this and additional works at: https://scholarsarchive.byu.edu/etd
Part of the Biochemistry Commons, and the Chemistry Commons

BYU ScholarsArchive Citation
Chen, Zhaoyuan, "Development of Methods for the Study of Phosphoproteins" (2006). Theses and
Dissertations. 1041.
https://scholarsarchive.byu.edu/etd/1041

This Dissertation is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for
inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more
information, please contact scholarsarchive@byu.edu, ellen_amatangelo@byu.edu.

DEVELOPMENT OF METHODS
FOR
THE STUDY OF PHOSPHOPROTEINS

by
Zhaoyuan Chen

A dissertation submitted to the faculty of
Brigham Young University
In partial fulfillment of the requirement for the degree of
Doctor of Philosophy

Department of Chemistry and Biochemistry
Brigham Young University
December 2006

BRIGHAM YOUNG UNIVERSITY
GRADUATE COMMITTEE APPROVAL

Of a dissertation submitted by
Zhaoyuan Chen
This dissertation has been read by each member of the following graduate committee and
by majority vote has been found to be satisfactory

_____________________________ _____________________________________
Date
Craig D. Thulin, Chair
_____________________________ _____________________________________
Date
Barry M. Willardson
_____________________________ _____________________________________
Date
Milton L. Lee
_____________________________ _____________________________________
Date
Allen R. Buskirk
_____________________________ _____________________________________
Date
Gerald D. Watt

ii

BRIGHAM YOUNG UNIVERSITY

As Chair of the candidate’s graduate committee, I have read the dissertation of Zhaoyuan
Chen in its final form and have found that (1) its format, citations, and bibliographical
style are consistent and acceptable and fulfill university and department style
requirement;(2) its illustrative materials including figures, tables, and charts are in place;
and (3) the final manuscript is satisfactory to the graduate committee and is ready for
submission to the university library.

___________________________ ______________________________________
Date
Craig D. Thulin
Chair, Graduate Committee

Accepted for the Department
______________________________________
David V. Dearden
Graduate Coordinator
Accepted for the College
______________________________________
Thomas W. Sederberg, Associate Dean
College of Physical and Mathematical Sciences

iii

ABSTRACT

DEVELOPMENT OF METHODS
FOR
THE STUDY OF PHOSPHOPROTEINS

Zhaoyuan Chen
Department of Chemistry and Biochemistry
Doctor of Philosophy
Characterization of phosphoproteins—including detection, identification of
phosphoproteins and identification of phosphorylation sites—is mostly done with
radiolabeling and proteomic techniques. Three main topics related to phosphoprotein
characterization are included in this dissertation. First, large-scale characterization of the
CHO (Chinese hamster ovary) cell phosphoproteome was done using two dimensional
gel electrophoresis (2DE) separation, visualization of phosphoproteins by radiolabeling
or a phosphoprotein specific dye, followed by MALDI-TOF identification. Because
radiolabeling of phosphoproteins is very sensitive and straightforward to quantify, such
analysis can give a clear picture of the relative phosphosphorylation of proteins present in
a sample. But there are also limitations to this approach, such as the inability of 2DE to
separate hydrophobic, acidic and large proteins and the poor detection limits of common
protein stains such as Coomassie stain. Additionally, it is difficulty to excise the right
spots for identification because of the low abundance of phosphoproteins which have
been visualized by radiolabeling. Furthermore, there are problems associated with
metabolic radiolabeling.
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A second topic of the dissertation is the development of a novel strong cation
exchange monolithic column for MudPIT (multidimensional protein identification
technology) and phosphopeptide isolation. This column, a poly(AMPS-co-PEGDA)
monolith containing as high as 40% AMPS, has several favorable features, such as high
binding capacity, extraordinarily high resolution, and high peak capacity, making it ideal
for resolving complex peptide samples. Application of this novel column to isolate model
phosphopeptides was shown. More general use of this column in MudPIT (strong cation
exchange column followed by reverse-phased MS/MS) is probably somewhat limited,
due to the hydrophobicity of the AMPS monomer. A better monolith could be obtained if
a more hydrophilic monomer was used.
In the third area of the dissertation, several individual protein phosphorylation
sites were analyzed, employing different strategies. Phosphorylation sites of one multiply
phosphorylated tryptic peptide from CK2-phosphorylated phosducin-like protein (PhLP)
was well characterized using enrichment with a MonoTip® TiO Pipette Tip. Analysis of
syntaxin 1a phosphorylation by AMPK (AMP-activated protein kinase) was done by
peptide level mapping for potential phosphopeptides after its unsuccessful trial with
enrichment using the MonoTip® TiO Pipette Tip. Several criteria such as existence of
non-phosphorylated forms of potential phosphopeptides, controls and reasonable
retention times were used to rule out false positives. Phosphorylation of syntaxin 1a by
AMPK was narrowed down to tryptic peptide T32 with evidence from different sources.
Three phosphorylation sites of syntaxin 4 by AMPK were identified within the same
peptide (Q65QVTILATPLPEESMK80). Further pinpointing of phosphorylation site(s) for
syntaxin 1a by AMPK and further confirmation of these phosphorylation sites in syntaxin
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4 by AMPK are required in vivo. The role of phosphorylation in syntaxin 4 by AMPK is
the next step toward elucidation of AMPK activation and regulation of the glucose uptake
mechanism.
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CHAPTER ONE

INTRODUCTION

1.1 PROTEIN PHOSPHORYLATION
Reversible protein phosphorylation was first discovered by Krebs and Fisher who
demonstrated that the interconversion of phosphorylase b to phosphorylase a involved a
phoshorylation/dephosphorylation mechanism [Fisher et al., 1955]. It was through the
1970s and 1980s that the general significance of protein phosphorylation came to be
appreciated. Many protein kinase cascades were identified during the 1990s. Now we
realize that protein phosphorylation is an integral part of all biological systems. No one
will doubt the statement that the reversible phosphorylation of proteins regulates nearly
every aspect of cell life. It is vital to many protein functions that are important to cellular
processes spanning the range from signal transduction, differentiation and development,
to cell cycle control and metabolism. The phosphorylation status of proteins is controlled
by two different classes of enzymes: protein kinases which catalyze the transfer of
phosphoryl groups from a high-energy compound to a nucleophilic acceptor on an amino
acid side-chain of proteins, and protein phosphatases which catalyze water-driven
hydrolysis of phosphoester bonds. Kinases and phosphatases modulate the protein
phosphorylation status of proteins in a cell. Kinases have been classified according to
their substrate specificity, being either tyrosine kinases, serine/threonine kinases, or dual
specificity kinases (which have both tyrosine as well as serine/threonine kinase
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activities). Just like their kinase counterparts, the protein phosphatases have been
categorized into two groups, the phosphoprotein Ser/Thr phosphatases (Ser/Thr PPases)
and the phosphotyrosine phosphatases (Tyr PPase), based upon substrate specificity. The
importance of these two classes of enzymes is also supported by their high number of
genes in the genome, constituting approximately 2% of the proteins encoded by the
human genome [Amit et al., 2002; Antonsson et al., 1998]. There are more kinases than
phosphatases due to their specificities (e.g. there are ~500 kinases and 100 phosphatases
in humans) [Venter et al., 2001]. It is estimated that one out of every three proteins is
phosphorylated at some point in its life cycle [Sickmann et al., 2001]. Several amino
acids in proteins can be phosphorylated by the four known types of phosphorylation
[Venter et al., 2001]. O-phosphates are the most common class and they are usually
attached to serine, threonine and tyrosine residues, but also to unusual amino acids such
as hydroxy-proline. Serine and threonine residues undergo phosphorylation more often
than tyrosine residues. The phosphoamino acid content ratio (pSer/pThr/pTyr) of a
vertebrate cell is approximately 1800:200:1. There is a higher gain in signals involving
tyrosine phosphorylation because it is less abundant and more tightly regulated [Hunter et
al., 1995]. N-, S- and acyl-phosphorylation are far less widespread and occur mostly on
histidine and lysine (N-phosphates), cysteine (S-phosphates) and aspartic and glutamic
acid residues (acyl-phosphates). In this dissertation, I will focus on o-phosphate type
phosphorylation on serine, threonine and tyrosine residues which are most common in
eukaryotic cells.
Phosphorylation leads to heterogeneity. Most phosphoproteins undergo
phosphorylation on more than one residue – this means that all the molecules of a given
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protein are not identically phosphorylated. Another characteristic of phosphorylation is
the ratio of phosphorylated to non-phosphorylated protein present in the cell
[Schlessinger et al., 1993-1994]. Some protein residues may be always quantitatively
phosphorylated, while others may only be transiently phosphorylated. The abundance of
phosphorylated forms of a protein can be as low as 1-2% of the total amount of that
protein [Kalume et al., 2003]. Phosphorylation is highly dynamic and intensely regulated,
and phosphorylation cycles may take place on a very short timescale. In addition to
problems concerning regulation, dynamics and abundance of phosphorylation, the
analysis is complicated by the complexity of phosphorylation patterns and the sheer
number of phosphorylation sites. There are more than 100,000 estimated phosphorylation
sites in the human proteome [Kalume et al., 2003].

1.2 PROTEIN PHOSPHORYLATION ANALYSIS
Despite a growing knowledge of many phosphorylation consensus sequences, this
posttranslational modification cannot usually be predicted accurately from translated
gene sequences alone. Additionally, we cannot predict when a site will be
phosphorylated. Thus, the experimental determination of sites of phosphorylation is an
important task. Analysis of protein phosphorylation usually includes phosphorylation
detection, phosphoprotein/phosphopeptide isolation and phosphorylation site
identification (PSI) by Edman degradation or MS-based methods. Various strategies for
protein phosphorylation detection have been developed throughout the years. Detection
of the phosphoprotein usually is the first step towards PSI.
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1.2.1 Protein Phosphorylation Detection
Based on an extra phosphate group on an amino acid residue, several methods
have been developed to visualize phosphoproteins.
1.2.1.1 Isotopic Label of Phosphoprotein
The use of the inorganic phosphate isotopes 32P or 33P (as in [γ-32P] ATP, for
example) to radiolabel phosphorylated proteins is probably the oldest method used to
study protein phosphorylation. It is still largely employed because it is simple, reliable
and sensitive for studying phosphorylation events in vitro and in cellular models. This
strategy takes advantage of cells taking up phosphates in media during metabolic
processes. So the usual procedure for this strategy is feeding cells with a radioactive
phosphorus isotope containing phosphate, lysing the cells, separating the cell lysate in
SDS-PAGE gel or a two-dimensional gel electrophoresis (2DE) and detection of
phosphorylation by autoradiography or a PhosphorImager system. The high sensitivity of
this method usually makes it a good choice to determine if a given protein is
phosphorylated particularly when stoichiometry of phosphorylation is low. Requirements
of in vitro metabolic labeling also bring problems for those situations when viable cells
are not available, for example with human biopsies, or when phosphoproteins have a
quick turnover rate. It also brings problems of different detection limits between gel
electrophoresis (SDS-PAGE gels or 2DE gels) and radiolabeling. Some proteins are
detected as phosphoproteins in gels by PhosphoImaging but not amenable to downstream
analysis such as PSI by MS because of the low amount of proteins present in gels.
Another disadvantage of the isotopic labeling is the safety and environmental concern.
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1.2.1.2 Direct Staining of Phosphoprotein
It would be fairly simple to visualize a phosphoprotein if there were reagents that
selectively detect phosphoproteins directly in SDS-PAGE gels. In this case, no viable
cells are required, and no safety or environmental issues are involved compared to
isotopic labeling method. Several methods have been described [Debruyne et al., 1983;
Cutting et al., 1973] to stain phosphoproteins directly in gels, but low specificity and
sensitivity have prevented these methods from being routinely applied. A recently
introduced fluorescent-based dye system called Pro-Q DiamondTM [Steinberg et al., 2003;
Schulenberg et al., 2003] makes direct staining more practical. Although the mechanism
for this stain is unknown due to proprietary patents, this dye selectively stains
phosphorylated proteins employing a very simple experimental protocol. The sensitivity
of staining depends on the number of phosphorylated residues present in the protein.
About 16 ng for pepsin (1 phosphorylated residue) and 2 ng for alpha-casein (8
phosphorylated residues) were the detection limits. Although it is quite sensitive, it is not
sufficient for comprehensive analysis of the phosphoproteome. Because of compatibility
of this dye with mass spectrometry analysis, it allows detection of phosphorylated
proteins and total proteins (with the SYPRO Ruby dye) on the same gel.
1.2.1.3 Western Blot Employing Phosphospecific Antibodies
Western blotting is a technique for identifying a certain protein in a sample by
using an antibody specific to that protein, in which proteins are separated by
electrophoresis, transferred to nitrocellulose and reacted with the antibody [Towbin et al.,
1979]. The development of antibodies against common protein epitopes allows the
identification of proteins sharing the same characteristics. In the case of the

5

phosphoproteome, the common epitopes are phosphoserine, phosphothreonine and
phosphotyrosine. The basic elements of this approach are the resolution of proteins in
gels, the selectivity and sensitivity of the antibodies and the sensitivity of the detection
system. All these elements were improved with the availability of high-resolution 2DE,
highly selective antibodies and high sensitivity detection systems [Kaufmann et al., 2001;
Buonocore et al., 1999]. Better anti p-Tyr antibodies are available because of the larger
size of p-Tyr compared to p-Ser or p-Thr. P-Ser or p-Thr specific antibodies are mostly
dependent on surrounding sequences in addition to the phosphorylated residue and are
thus more likely to be less specific and of lower affinity. The specificity and affinity of
antibodies play a key role in the applicability of this approach due to false positive
detection in this process. This is part of the reason that anti p-Tyr containing
phosphoproteins are much better studied [Godovac-Zimmermann et al., 1999; Soskic et
al., 1999] with this approach, although they are less abundant than their counterparts.
Better anti p-Ser and anti p-Thr antibodies are needed to achieve the same result as anti pTyr antibodies [Wagner et. al 1991; Yang et al., 2001]. A fairly exhaustive evaluation of
the specificity and reliability of commercially available anti p-Ser and anti p-Thr
antibodies has been done [Grønborg et al., 2002]. Although Western blotting has a very
low detection limit for phosphoproteins, this method is not very suitable for quantitative
analysis due to the variability of the amount of proteins transferred to the membrane from
one SDS gel to another, which necessitates an internal standard.
1.2.1.4 Detection of Phosphoproteins Employing Phosphatases
Phosphatases hydrolyze phosphate groups off phosphoproteins, which change the
net charge and molecular weight of the proteins and, thus, the migration behavior during
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2D gel electrophoresis. These changes have been exploited to discriminate
phosphorylated from unphosphorylated proteins. The specific enzymatic activity of λphosphatase (λPPase) on p-Ser, p-Thr, p-Tyr and p-His residues, combined with the high

Figure 1. Detection of phosphoproteins employing λ-phosphatase (λPPase). The starting
sample is divided in two aliquots, one of which is treated with λ-PPase. Subsequently,
both samples are analysed by 2D gel electrophoresis. Phosphorylated proteins are
identified by comparison of the 2D protein patterns exploiting the different migration
’behaviour’ due to loss of phosphate groups as can be seen by comparing spots 1 and 2 in
parts A1 and B1 of this figure which represent enlarged views of a 2D gel. Comparing
these spots in a 3D view (see A2 and B2), differences in spot volume are even more
evident [Reproduced from Yamagata et al., 2002].
7

resolution power of 2D gel electrophoresis has led to the identification of some novel
phosphoproteins in cultured rat fibroblasts [Yamagata et al., 2002]. The strategy is shown
in Figure 1. [Reproduced from Yamagata et al., 2002].

1.2.2 Phosphopeptide Recognition
Once the nature of a protein has been identified, its phosphorylation status can be
ascertained by revealing the occurrence of phosphopeptides within its proteolytic digest.
Detection of protein phosphorylation may be done by MS based methods, but it is usually
done by other aforementioned non-MS based methods. Recognition of phosphorylation
of peptides, on the other hand, is mostly done by MS based methods. The following are
some most common techniques used to recognize phosphopeptides.
1.2.2.1 Molecular Mass Shift and Phosphatase Treatment
The basic idea of this method is measurement of all the tryptic peptides usually
with MALDI-TOF-MS, which has a wide range of m/z detection limits and then compare
these values with theoretically expected values. A molecular mass shift by single or
multiples of +80 Da (HPO3 = 80 Da) indicates that it is a phosphopeptide [Mann et al.,
2003]. Practically, this method has many difficulties. It is hard to obtain m/z values of all
the peptides in the tryptic mixture. Detection of phosphopeptides is worse because of the
usual low stoichiometry of phosphopeptides, weak ionization of phosphopeptides in the
positive ion mode due to the extra negative charge brought by phosphate group(s) and
signal suppression from non-phosphopeptides. Several strategies have been used to
alleviate these negative effects. Enrichment of phosphopeptides can alleviate both
problems of low stoichiometry of phosphopeptides and the suppression from non-
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phosphopeptides. Details of the enrichment of phosphopeptides are discussed in a later
chapter. Addition of phosphoric acid and ammonium salts to conventional 2′,4′,6′trihydroxy-acetophenone based MALDI-matrices [Kjellstrom et al., 2004; Asara et al.,
1999; Yang et al., 2004] improves suppression in the MALDI spectrum. Negative ion
mode can also be used to improve poor inionization of phosphopeptides [Janek et al.,
2001; Ma et. al 2001].
Even with these improvements, MALDI-TOF-MS recognition of phosphopeptides
is complicated by the isobaric peptides in the sample. Using phosphatases combined with
MALDI-TOF-MS has been popular to solve this problem. By comparing sample spectra
with and without phosphatase treatment, a characterisitic shift of one multiple of -80 Da
in molecular mass indicates phosphopeptides due to the cleavage of HPO3 from the
phosphopeptides by phosphatases [Stensball et al., 2001; Larsen et al., 2001a; Larsen et
al., 2001b]. Major drawbacks of this approach are again related to the decreased
ionization of phosphopeptides in complex mixtures due to ionization suppression effects.
Different chemical derivatization approaches based on β-elimination/Michael addition
chemistry have been developed to alleviate problems related to weak
ionization/suppression phenomena for phosphopeptides in the positive ion mode [Molloy
et al., 2001; Thompson et al., 2003 Knight et al., 2003].
1.2.2.2 Precursor Ion Scan (PIS)
PIS and neutral loss scan (NLS) for detection of phosphopeptides both require
collision induced dissociation (CID) in their detection. The specific fragmentation
behavior of phosphopeptides can be used to recognize a phosphopeptides by mass
spectrometers capable of PIS and neutral loss scanning (NLS). Briefly, monitoring the
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small negative ions such as phosphate (PO3−) (m/z =−79) from p-Ser, p-Thr or p-Tyr in
the negative ion mode is called precursor ion scanning. Detection of PO3− identifies the
corresponding precursor phosphopeptide ion by its m/z value as performed in Figure 2
[Steen et al., 2001b; Reinders et al., 2005]. This method is very sensitive with a nano-ESI
source [Wilm et al., 1996; Carr et al., 1996; Watty et al., 2000; Verma et. al; 1997]. If
further MS/MS fragmentation of phosphopeptides is desired, the third MS must be
switched back to the positive ion mode and the buffer must be switched to an acidic
buffer as well. A strategy to separate the LC eluant for both phosphopeptide detection
and phosphopeptide tandem MS fragmention has been reported [Zappacosta et. al; 2002].
The positive ion mode in PIS was also used to scan and detect p-Tyr-containing peptides
[Steen et al., 2001a; Steen et al., 2001b]. P-Tyr-containing peptides have the
characteristic fragment under CID, the immonium ion (an internal fragment with just a
single side chain formed by a combination of a type and y type cleavage) containing ptyrosine side chain with m/z=216.043. But this method requires high-resolution MS
[Chernushevich et al., 2001] to distinguish this immonium ion from other peptide
fragment ions such as b-ions AsnThr or GlySer (both m/z=216.098 Da) and y2-ion-NH3
AspVa1 (m/z=216.069 Da), etc. Because the scan happens in the positive ion mode, there
is no need to change the ion polarity for the further fragmentation. Subpicomolar
sensitivity for detection of tyrosine phosphorylation sites from protein digests has been
reached.
A similar, not commonly performed process called stepped skimmer potential in
ESI was also used to fragment phosphopeptides and monitor the characteristic m/z -63
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(PO−) and−79 (PO3−) ions to recognize phosphopeptides [Huddleston et al., 1993; Ding et
al., 1994; Jedrzejewski et al., 1997].
1.2.2.3 Neutral Loss Scan (NLS)
Compared to PIS, which scans the negative phosphate (PO3−), the neutral loss of
phosphoric acid (−98 Da) or a dephosphorylation (−80 Da) [122] during gas-phase βelimination of pSer/pThr-containing peptides can not be detected by MS directly. But
characteristic ions with m/z shifts of 49, 32.6 and 24.5 (for doubly, triply and quadruply
charged ions, respectively) with respect to parent ions indicate phosphopeptides. This
method is called neutral loss scan. This scan generally is not applicable to pTyrcontaining peptides because β-elimination usually does not happen for them. Method
drawbacks are the incidence of false-positive signals in automatic visualization of
peptides affected by neutral loss events as well as the dominant occurrence of phosphateloss specific fragment ions in the MS/MS spectra [Beausoleil et al., 2004]. Both PIS and
NLS can be used as driving information for automated data-dependent acquisition in MS

Figure 2. Schematic view of a triple quadrupole mass analyzer operating in precursor ion
scanning (PIS) or neutral loss scanning (NLS) modes.Quadrupole 1 (Q1) scans repeatedly
through the entire mass range while Q2 is used as a collision cell. In PIS mode Q3 is used
to monitor a certain fragment ion mass, e.g., m/z = 216.043 Da for the immonium ion of
phosphotyrosine. However, in NLS mode Q3 scans through the mass range with a
distinct offset to Q1 corresponding to a neutral loss of the peptide such as loss of the
phosphate-group of pSer or pThr (Dm =298 Da/280 Da) [Reinders et al., 2005].
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with sufficient resolution and fast scanning rate, i. e. triple quadrupole [Schlosser et al.,
2001], ion trap [Beausoleil et al., 2004,D’Ambrosio et al., 2006a] and q-TOF mass
spectrometers [Trinidad et al., 2006; Nousiainen et al., 2006].
1.2.2.4 31P Detection
Usually no other places other than phosphate groups in proteins/peptides will 31P
be found, under conditions that no 31P-containing inorganic contaminants are present. So
inductively coupled plasma (ICP) ionization-based instruments [Wind et al., 2001b], such
as element mass spectrometry can be used to monitor 31P occurrence, thus, recognizing
phosphopeptides. ICP ionization and detection of 31P is not affected by suppression
effects as in ESI/MALDI ionization, so absolute quantitation can be achieved. The
average phosphate content of proteins can also be determined with ICP-MS by measuring
the 31P/32S ratio [Wind et al., 2001a].

1.2.3 Phosphorylation Site Identification
After the detection of phosphorylation of proteins/peptides, localization of the
exact phosphorylation site becomes important. Methods for PSI are compared to reveal
their advantages and drawbacks. MS-based methods are discussed in more detail than
non-MS based methods for practical reasons and the sake of this dissertation.
1.2.3.1 Comparison Among PSI Methods
Before the availability of MS-based methods for accurate pinpointing of
phosphorylation sites, methods that involved 32P-labeled phosphoproteins using
phosphopeptide mapping [Van der Geer et. al 1994; Boyle et. al 1991; Nagahara et. al
1999] and Edman degradation [Van der Geer et al., 1994] were well-established, but not
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without their limitations. Briefly, phosphopeptide mapping for identification of
phosphorylation sites is based on digestion of 32P-labeled proteins with site-specific
proteases and separation of the digestion products in two dimensions on thin-layer
cellulose plates using electrophoresis in the first dimension followed by chromatography.
Phosphopeptide maps are obtained after autoradiography of the two dimensional
cellulose plates. The position of the spot on the image indicates the specific peptide that
is phosphorylated, which potentially gives the phosphorylation site assignment. The
Edman degradation approach is based on Edman sequencing of purified phosphopeptides,
which result from the digestion of 32P-labeled protein with a protease and purification of
resulting phosphopeptides by reversed-phase HPLC or thin-layer chromatography.
Phosphorylation sites can be determined by measuring the radioactivity of each fraction
from each Edman cycle using a scintillation counter.
32

Requirement for
radioactivity
Sensitivity
Localization of
sites
Coverage

P-labelling and
phosphopeptide
mapping
Large amounts
required
Most sensitive
Difficult without
mutagenesis
experiments
Full coverage is
difficult

High-throughput
operation

Not possible. Very
labor intensive

Purified protein
required

Yes

Edman sequencing

Mass spectrometry

May be used

Not required

Less sensitive
Highly sensitive
(pmol)
(fmol)
Possible. Tyrosine
Definitive
residues are
localization is
problematic
possible
Full coverage is
Full coverage is
possible, provided difficult. FTMS may
sufficient material is
provide full
available
coverage
Difficult
Possible with
automated LCMS/MS setups
Yes
No

Table 1. Comparison of mass spectrometry-based techniques with other methods for
phosphorylation analysis of peptides [Kalume, et. al 2003].
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The MS-based methods have become popular recently, and will be discussed in detail in
the next section. The advantages and limitations of each method are clearly shown in
Table 1 [Kalume, et. al 2003]. With the advantages of no radiolabeling required, no
protein purification required, high sensitivity, decent coverage and high-throughput; MSbased methods are becoming the methods of choice for PSI. However, in many cases,
more than one method may be employed for the study of phosphorylation site
identification [Loyet et al., 2003].
1.2.3.2 MS-based Identification Methods
All MS-based PSI methods are based on the fragmentation of phosphopeptides
and the use of algorithms to determine the phosphorylation site(s). A tandem MS is
usually required for this purpose. After ionization of peptides from a proteolytically
digested phosphoprotein of interest with one of the two most popular ionization sources
(MALDI and ESI), the first MS scans through the entire mass range and allows a
specific m/z species to proceed into the collision cell for fragmentation with an inert gas.
The fragments are then scanned by the second MS and sent to a detector to measure its
m/z. With two ionization sources, many MS/MS combinations, different fragmentation
methods and several different types of detectors, the possible combinations for
phosphorylation studies are large. Discussion of all the possibilities is beyond the scope
of this introduction. Based on the different fragmentation methods, only popular
combinations used for novel PSI study are discussed.
1.2.3.2.1 Collision Induced Dissociation (CID) and LC-ESI-MS/MS
CID is the most common fragmentation method used in PSI so far. CID uses inert
gases, such as argon or nitrogen to collide with accelerated peptides to produce peptide
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fragments for de novo sequencing. Several factors make LC-ESI-MS/MS the most
popular combination for PSI in this category. In this combination, an ESI source is used
for peptide ionization after separation by on-line LC. The use of LC greatly reduces the
sample complexity by first resolving it chromatographically. There are other important
methods to reduce non-phosphopeptides and enrich phosphopeptides, and they will be
further discussed in the phosphopeptide/phosphoprotein enrichment chapter. One reason
ESI is a preferred ionization source is due to the different natures of ionization of
MALDI and ESI. MALDI ionization tends to produce singly charged peptides, while ESI
tends to produce doubly and triply charged peptides. Generally, modification assignment
is achieved more easily with doubly or triply charged parent ions produced by an ESI
source. The specific m/z species selected by the first MS will be fragmented by CID.
There are two more recently developed fragmentation methods: electron capture
dissociation (ECD) and electron transfer dissociation (ETD). Because of the specialized
tandem MS required, these will be discussed in a later section. Fragmented species will
be scanned for their m/z by “the second” MS, which is actually the third MS because the
second MS serves as a collision cell. Many types of tandem MS are used for this
combination and they are the dominant methods for novel phosphorylation site
identification, for example, triple quadrupole [Neubauer et al., 1999; Zappacosta et al.,
2002], ion trap- [Beausoleil et al., 2004; D’Ambrosio et al., 2006a], hybrid q-TOF
[Trinidad et al., 2006; Merrick et al., 2001] and Fourier transform ion cyclotron
resonance (FTICR) [Haas et al., 2006; Chalmers et al., 2003] instruments have been used.
Several popular algorithms such as Analyst, Sequest and SALSA are used to map the
sequence of phosphopeptides and phosphorylation site(s). It is difficult and unwise to
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analyze all peptides eluted (including phosphopeptides) even after improved resolution of
peptides in a complex proteolytic mixture using LC.
Strategies have been developed to selectively fragment peptides eluted from online LC columns. In fact, MS/MS analysis is usually carried out automatically by
repeated MS scanning of the chromatographic peaks and subsequent multiple selections
of the most intense ions from a given scan for CID-generated fragmentation data for
many peptides (including phosphopeptides) in the sample. This is called informationdependent acquisition (IDA), or more accurately, intensity-dependent acquisition. In the
IDA mode, the achievement of good fragmentation data for phosphopeptides may be
hindered by the presence of more co-eluting peptides (limiting the time available for
recording good MS/MS spectra of each species) and their occurrence as substoichiometric species (limiting the relative parent ion MS signal intensity) [Steen et al.,
2006]. Thus, PIS or NLS-driven (in the positive ion mode) automated informationdependent acquisitions are routinely used during analysis of phosphopeptide containing
mixtures [Steen et al., 2006; Beausoleil et al., 2004; Haas et al., 2006; Chalmers et al.,
2003]. With software capable of predicting precursor and neutral loss fragment ion m/z
values, NLS-driven IDA of product ion scans and MS/MS/MS (MS3) experiments are
conducted on hybrid quadrupole linear ion trap instruments to generate informative data
from further fragmentation of fragment ions generated by neutral loss in MS2-spectra [Jin
et al., 2004] in the study of phosphorylation of pSer/pThr-containing phosphoproteins.
The resulting MS3- spectrum provides significantly more structural information than the
MS2-spectrum, with a spacing of 69 Da (owing to dehydroalanine, Dha) or 83 Da (owing
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to dehydroaminobutyric acid, Dhb) indicative of the exact location of pSer and pThr
residues, respectively [Lalle et al., 2006; Gruhle et al., 2005].
In addition to the ESI source, the MALDI source has also been coupled to tandem
mass spectrometers for PSI, especially with the availability of instruments such as the
quadrupole-TOF (MALDI-q-TOF), TOF-TOF (MALDI-TOF-TOF), or ion trap
(MALDI-ion trap). This allows increased efficiency and sample throughput because
identification of phosphopeptides and assignment of the modification sites based on
MS/MS sequencing can be performed on a single sample spot [Laiko et al., 2000; Bennett
et al., 2002]. As compared to the ESI source, the weaknesses associated with MALDI
source ionization (limited sequence coverage and weak ionization/suppression effects for
phosphopeptides) have not been obviated with the introduction of these instruments.
1.2.3.2.2 Post Source Decay and MALDI-TOF-MS
PSD refers to the fragmentation of molecular ions during their flight times in the
MS, subsequent to ionization and acceleration away from the ionization source. All
precursor ions leaving the ion source have approximately the same kinetic energy. During
the flight time, the precursor ions fragment, resulting in smaller product ions. The product
ions have almost the same velocity as their precursors, but differ in their kinetic energies
(corresponding to their m/z). MALDI-TOF is the combination of choice for coupling to
PSD because of high sensitivity, simple instrumentation and much higher tolerance of
MALDI to buffer and salt contaminants in comparison to ESI. Without tandem MS
fragmentation, it is hard to directly assign phosphorylation sites. However, there are some
successful examples of assigning low intensity signals to polypeptide backbone
fragments observed in the course of PSD experiments [Annan et al., 1996; Neville et al.,
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1997; Vener et al., 2001]. When phosphorylation occurs within the target sequences of
Pro-directed kinases (Ser-Pro and Thr-Pro motifs), cleavage of the intervening amide
bond is highly preferred, making characterization much easier [Hoffmann et al., 1999].
1.2.3.2.3 Latest Developments
Recently two similar fragmentation methods were introduced. These are electron
capture dissociation (ECD) and electron transfer dissociation (ETD). ECD is a method of
fragmenting gas phase ions for structural elucidation in MS. It involves introduction of
low energy electrons to trapped gas phase ions and produces significantly different types
of fragment ions (mostly c and z ions) than other fragmentation methods such as CID
(mostly b and y ions) [Shi et al., 2001; Mclafferty et al., 2001]. The unique (and
complementary to CID) fragmentation of phosphopeptides, including maintaining
phosphorylated amino acid side chains intact and obtaining efficient peptide backbone
fragmentation [Stensballe et al., 2000], make it much easier to assign a modification. It
also has the ability to fragment large peptides or proteins, for which no proteolytic
digestion is needed [Shi et al., 2001; Jebanathirajah et al., 2005]. Drawbacks are the
necessity of high resolution, expensive FTICR MS and skilled personnel.
Different from ECD, which uses direct electrons, ETD uses anions, such as singly
charged anthracene anions, to transfer electrons to protonated peptides, which leads to a
similar fragmentation of the peptide backbone [Syka et al., 2004]. ETD enables the use of
this type of fragmentation in a lower resolution ion trap MS [Schroeder et al., 2005].

1.3 PHOSPHOPEPTIDE/PHOSPHOPROTEIN ENRICHMENT METHODS
Only a fraction of the total proteins in a proteome are phosphorylated at any given
time. This not only means that only a fraction of the total protein species are
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phosphorylated, but also means that only a fraction of any given species is
phosphorylated, which is often as low as 1%. The normal procedure of MS-based PSI
involves the protease digestion of phosphoproteins, which gives mostly nonphosphopeptides and a few phosphopeptides. Even starting with 100% phosphoproteins,
the phosphopeptides are still the minority among proteolytically digested peptides.
Negatively charged phosphate side chains on phosphopeptides prevent them from
ionizing as well as non-phosphopeptides with MS performed in its usual positive ion
mode. All of these facts, combined with the detection of phosphopeptides by MS often
being hindered because of suppression effects, necessitate the enrichment of
phosphoproteins or phosphopeptides. Many different strategies for separating
unphosphorylated species from phosphopeptides have been established. The three major
strategies are immunoprecipitation, affinity chromatography and chemical derivatization.

1.3.1 Phosphoprotein Enrichment
The above mentioned three strategies have been all applied to enrich
phosphoproteins. A survey of the different strategies for phosphoprotein enrichment is
shown in Figure 3 [D'Ambrosio et al., 2006b].
Although there are examples for enrichment of phosphoproteins by
IMAC/MOAC [Anderson et al., 1986; Metodiev et al., 2004] or anti-pSer/pThr antibody
immunoprecipitation [Carty et al., 2002; Stannard et al., 2003], they are not that
commonly performed. On the other hand, the use of SDS-PAGE/2DE or anti-pTyr
antibody immunoprecipitation to isolate or enrich phosphopeptides is routine [Pandey et
al., 2000].
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1.3.2 Phosphopeptide Enrichment
Phosphopeptide enrichment is still a necessary step for most phosphoproteins due
to suppression effects from the large amount of non-phosphopeptides. In a large scale
study of phosphorylation, such as in a phosphoproteome, good phosphopeptide

Figure 3. Different techniques for the enrichment and analysis of phosphoproteins based
on MS procedures [D'Ambrosio et al., 2006b].
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enrichment methods serve at once for all purposes, and no intermediate phosphoprotein
enrichment is needed. It enriches all the phosphopeptides from all phosphoproteins
digested in a complex mixture. Most strategies applied to phosphoprotein enrichment can
apply to phosphopeptide enrichment as well. Much more effort has been put into
phosphopeptide enrichment method improvement and innovation. Only some of the most
popular methods will be covered in this introduction.
1.3.2.1 Affinity Methods (IMAC)
Immobilized metal affinity chromatography (IMAC) was originally introduced for
purification of His-tagged proteins [Porath et al., 1975] and is the most frequently applied
technique for phospho~peptide and -protein enrichment [McLachlin et al., 2001]. The
theory behind IMAC is based on the electrostatic interaction between the negatively
charged phosphate groups and positively charged metal ions which are immobilized to
the column material via iminodiacetic acid (IDA), nitriloacetic acid (NTA) or Tris(carboxymethyl)-ethylendiamine (TED) chelators. It is obvious that more negatively
charged groups, such as multiply phosphorylated peptides and very acidic peptides will
be predominantly enriched [Stensballe et al., 2001]. Esterification of the acidic side
chains of glutamate and aspartate residues using HCl-saturated, dried methanol has
alleviated the problem of interaction with acidic peptides [Conrads et al., 2002; Ficarro et
al., 2002]. However, the extra modification step may complicate the samples by
incomplete esterification, interfere with subsequent mass spectrometric analysis and
encumber automation for large scale phosphoproteome-wide analysis. Another possibility
for decreasing the co-purification of acidic peptides is the use of the more selective TiO2columns [Sano et al., 2004]. The greatest disadvantage of this IMAC is still non-specific
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interaction by other negative groups such as side chain carboxylic acids from aspartate
and glutamate. Again,this is because the interaction is between a positively charged metal
and any negatively charged group.
Various metal ions such as Fe3+, Ga3+, Al3+ or Zr4+ have been tested for better
selectivity and phosphopeptide recovery [Liu et al., 2003; Nuhse et al., 2003]. Ga3+ ions
have proven effective [Posewitz et al., 1999] in different studies. However, Fe3+-based
methods are still used more often. The good compatibility of IMAC procedures with
subsequent separation and detection techniques such as CE and LC-MS/MS make it
popular in the large scale analysis of phosphorylation.
Because automation is an important factor for large scale phosphoproteome
studies, any extra chemical modification involved will compromise high-throughput. In
an effort to reduce the non-specific binding, I have proposed a strategy taking advantage
of the high specificity and affinity of bacteriophage λ phosphoprotein phosphatase
mutants as affinity reagents for enrichment of phosphopeptides.
1.3.2.2 Immunoprecipitation
Compared to immunoprecipitation of p-Ser/p-Thr antigens using expensive,
antibodies of questionable quality, the immunoprecipitation of p-Tyr-containing proteins
[Mann et al., 2002] is much more frequently practiced [Gronborg et al., 2002]. As
previously mentioned, the smaller size of p-Ser and p-Thr compared to p-Tyr, makes it
difficult to raise good antibodies again them. Immunoprecipitation of phosphopeptides
using phosphopeptide-specific antibodies is also usually not successful [Marcus et al.,
2000; Sun et al., 2001; Oda et al., 2001] and other methods must be applied.
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1.3.2.3 Derivatization Methods
Chemical modification methods have been developed and improved over the last
five years. The first method in this category used chemical tagging of the phosphate
group based on gas-phase β-elimination and Michael addition chemistry [Oda et al.,
2001] as in panel A and B of Figure 4. This methed only applies to p-Ser/p-Thr residues,
because p-Tyr does not undergo β-elimination. Another important innovation was a
multi-step derivatization procedure that is capable of enriching not only Ser/Thrphosphorylated peptides, but all types of phosphorylated peptides [Zhou et al., 2001].
There have been many modifications of these methods since they were originally
developed. Most of them are listed in Figure 4. The detection limits were improved as the
methods were more finely tuned.
Although many methods have been reported in this category, application of most
methods is rarely performed outside method-development laboratories themselves, partly
because of the delicate derivatization reactions involved. The necessary extra
modification reaction(s) may lead to sample loss, increase of sample complexity and
unexpected modification of peptides. Automation is a key factor for phosphoproteomewide analysis, which is made more difficult by the extra reaction step(s) involved in these
modification methods.
1.3.2.4 Recent Developments
TiO2 particles [Pinkse et al., 2004; Larsen et al., 2005; Liang et al., 2006] and
ZrO2 particles [Kweon et al., 2006] have been recently used to enrich phosphopeptides.
These particles work in the same way as IMAC columns, through interaction is between
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Figure 4. Various strategies for the enrichment of phosphopeptides based on different
chemical modification reactions. (Panel A) Base-catalyzed β-elimination of pSer and
pThr yielding Dha and Dhb, respectively. Enrichment approaches by chemical tagging of
the phosphate group based on a β-elimination/Michael addition chemistry [Oda et al.,
2001] (panel B), [Tseng et al., 2005] (panel C), [Vosseller et al., 2005 ] (panel D),
[McLachlin et al., 2003] (panel E), [Qian et al., 2003] (panel F). Enrichment approaches
by chemical tagging of the phosphate group based on a carbodiimide condensation
chemistry [Zhou et al., 2001] (panel G) and [Tao et al., 2005] (panel H). Depending on
the possibility to perform quantitative measurements, X corresponds to H or D (panel D
and H); similarly X and Z correspond to 12C or 13C and 14N or 15N, respectively (Panel
F) [D’Ambrosio et al., 2006b].
negatively charged phosphates and positively charged ions. With the particle size in the
nanometer range, better enrichment efficiency was achieved when used as a precolumn
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[Liang et al., 2006]. Specificity is always a big issue with this type of affinity
chromatography. The specificity of TiO2 particles is improved by adding 2, 5dihydroxybenzoic acid (DHB) in the peptide loading buffer [Larsen et al., 2005]. The
reason has been speculated to be the competition between DHB and non-phosphopeptides
in one binding mode with TiO2, while phosphopeptide binding is unaffected in the other
mode. Phosphopeptide enrichment microtips made of TiO2 tend to selectively isolate
multiply phosphorylated peptides, while ZrO2 microtips tend to enrich singly
phosphorylated peptides, so these two chromatographic materials possess complementary
properities [Kweon et al., 2006].
Application of strong cation exchange columns to separate phosphopeptides from
non-phosphopeptides based on the extra negative charge brought by the phosphate group
in the phosphopeptide, were also reported [Peng et al., 2003]. Details of this approach
will be discussed the third chapter of this dissertation.
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CHAPTER TWO

CHARACTERIZATION OF PHOSPHOPROTEINS BY TWO DIMENSIONAL
GEL ELECTROPHORESIS AND MASS SPECTROMETRY

2.1 INTRODUCTION
Since the discovery in 1955 that reversible phosphorylation regulates the activity
of glycogen phosphorylase [Fisher et al., 1955] there has been intense interest in studying
protein phosphorylation. Phosphorylation and dephosphorylation of proteins regulate a
variety of essential biological functions. Generally, the phosphorylation state of a protein
cannot be predicted from the gene sequence, and thus needs to be determined at the
protein level. Currently there are two popular approaches for examining the
phosphoproteins at large scale (the phosphoproteome). Strategy one involves digesting
the proteins, detaching the phosphopeptides from non-phosphopeptides by various
methods discussed in Chapter one (affinity chromatography, immunoprecipitation and
derivatization methods), and then identifying these peptides by tandem mass
spectrometry (MS/MS) [Ficarro et al., 2002]. The other strategies involve separation of
the proteome first with two-dimensional gel electrophoresis (2DE) [Shevchenko et al.,
1966] and then visualization of the phosphoproteins by one of the aforementioned
methods [Khan et al., 2005; Hayduk et al., 2004]. Here we apply in vitro 32P labeling of
phosphoproteins and visualization of phosphoproteins by autoradiography or applying a
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phosphate-specific stain directly to the phosphoproteins separated by 2DE. Although
protein separation followed by phosphoprotein visualization is not as facile as
identification by affinity methods, it does have the advantage of providing a view of the
phosphoproteome as a subset of the overall proteome and relative quantification of each
visualized phosphoprotein. In view of these advantages, we undertook a cursory
examination of the phosphoproteome of Chinese hamster ovary (CHO) cells, including a
comparison of radiolabeling and phosphoprotein-specific fluorescence staining.
CHO cell line was chosen because it is easily manipulated genetically and can be
adapted to a wide variety of growth conditions including growth in suspension culture
and in chemically defined media. As CHO cells are currently the mammalian host of
choice for producing human therapeutics [Walsh et al., 2003], the importance of studying
CHO cells is known for their generation of glycoproteins with similar oligosaccharide
structures to those produced from normal human diploid cells or isolated from human
urine glycoproteins [Goocheee et al., 1991]. Because the CHO cell genome has not been
sequenced, it is likely that proteomics-wide studies such as phosphoproteomics will shed
light on signal transduction studies involving phosphorylation.

2.2 MATERIALS AND METHODS
2.2.1 32P-Labeling of Chinese Hamster Ovary Cell Phosphoproteins
Tissue culture plates (60-mm diameter) of CHO cells were grown to 100%
confluency. The growth medium was removed, and cells were washed with phosphatefree Dulbecco’s modified Eagle's medium (DMEM) (Gibco, Carlsbad, CA) three times.
The cells were then incubated in 3 mL of phosphate-free DMEM with 100 µCi of
K2H32PO4 (Perkin Elmer, Boston, MA) for 4 to 18 h, with or without adding 5 µL of 1
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mM microcystin-LF (Sigma Aldrich, St Louis, MO). Following incubation, the 32Pcontaining medium was removed, and the cells were washed three times with phosphatebuffered saline and extracted with 200 µL 1% of sodium dodecyl sulfate (SDS).

2.2.2 2D Electrophoretic Analysis
Protein extracts from cells were acetone-precipitated by addition of 9 volumes of
ice-cold acid acetone (acidified with one drop of 6 N HCl in 10 mL of acetone) followed
by vortexing and incubation at -80º C for at least 1 h. After spinning for 10 min at 13,400
X g at 4 º C, acetone pellets were air dried and dissolved in rehydration buffer (7 M urea,
2 M thiourea, 15 mM dithiothreitol, 4% Triton X-100, and 1% pharmalytes). The first
dimension (isoelectrofocusing) employed Amersham IPG strips (pH 3–10) on the
Multiphor II apparatus (Amersham Pharmacia, Piscataway, NJ). Proteins in
electrofocused IPG strips were reduced in 32 mM dithiothreitol and alkylated using 216
mM iodoacetamide. The second dimension was run on a 10% SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) gel. The 2D gels were stained with colloidal Coomassie
(Pierce, Rockford, IL), equilibrated with 5% glycerol, and dried onto Whatman filter
paper; radioactivity was visualized on a Storm 860 phosphorimager (Molecular
Dynamics, Sunnyvale, CA).

2.2.3 Identification of Proteins from Excised Gel Spots
Spots that were excised from 2D gels were trypsinized in gel according to the
developed method (Shevchenko et al., 1996) then desalted and concentrated using µC18
ZipTips (Millipore, Billerica, MA). Samples were spotted on a matrix-assisted laser
desorption/ionization (MALDI) plate with an equal volume of α-cyano-hydroxycinnamic
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acid as the matrix. MS employed a QSTAR Pulsar i instrument equipped with an
orthogonal MALDI (oMALDI) source (Applied Biosystems, Framingham, MA). MS
spectra of the digests were obtained and parent ions selected from each digest for
collision-induced fragmentation. The collision-induced fragmentation spectra were then
submitted to the Mascot website (Matrix Science, London, UK) for database searching.

2.2.4 Pro-Q Diamond Stain of Chinese Hamster Ovary Cell Extract
Tissue culture plates (60-mm diameter) of CHO cells were grown to 100%
confluency. Plates were washed with phosphate-buffered saline, extracted with 1% SDS
or incubated with phosphate-free DMEM media overnight, and harvested with 1% SDS.
Cell extracts were acetone precipitated and subjected to 2DE apparatus as above. Gels
were stained with Pro-Q Diamond phosphoprotein gel stain (Molecular Probes, Eugene,
OR) according to the manufacturer’s protocol. These gels were visualized using the
DarkReader DR45M Transilluminator (Clair Chemical Research, Doroles, CO).
Subsequently, these gels were stained with Sypro Ruby stain (Bio-Rad, Hercules, CA) for
total proteins.

2.2.5 2D Gel Image Processing
Images of gels stained with colloidal Coomassie, Sypro Ruby or Pro-Q Diamond
were captured with the AlphaDigiDoc system (AlphaInnotech, San Leandro, CA). These
images, as well as phosphorimages, were analyzed using the Melanie 4 software package
(GeneBio, Geneva, Switzerland).
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2.3 RESULTS AND DISCUSSION
2.3.1 Overview of the Phosphoproteome Compared with the Entire Proteome

Figure 5. Two-dimensional electrophoresis of proteins and phosphoproteins of Chinese
hamster ovary cells. Coomassie-stained gel (A) and corresponding phosphorimage (B) of
proteins extracted from Chinese hamster ovary cells labeled for 4 h with 32P–phosphate.
Crosses indicate matched spots.
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Figure 6. Number of spots in different categories. Proteins are grouped according to
their appearance in phosphorimage, Coomassie-stained gel, or both.

Our initial objective was to examine the phosphoproteome as it compares with the
abundance proteome (the abundant proteins, as detected by Coomassie blue stain). For
this comparison, Melanie 4 detected 468 spots in the Coomassie-stained gel (Figure 5A),
and 181 spots in the phosphorimage (Figure 5B). Thus, the observable phosphoproteome
is about one third the size of the abundance proteome. However, this does not mean that
one third of the proteome is phosphorylated. Low-abundance proteins are not visualized
by Coomassie stain. In contrast, radiolabeling allows visualization of even fairly low
abundance phosphoproteins (although we have not determined our limit of detection).
Although the images in Figure 1 are from the same gel, only 51 spots in the
phosphorimage match spots on the Coomassie-stained gel (indicated by crosses in Figure
5). Around 72% of phosphoproteins (130 out of 181, see Figure 6) cannot be matched
with counterparts in the Coomassie-stained gel. Thus, most phosphoproteins are low-
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abundance proteins, falling below the limit of detection of the Coomassie blue stain. It is
tempting to use these data to determine the proportion of the proteome that is
phosphorylated. Fifty-one of 468 (11%) proteins observed by Coomassie blue stain were
apparently phosphorylated. Using this ratio one might extrapolate to the entire proteome,
assuming that the ratio of phosphoproteins as a subset of protein observed is similar for
the low-abundance proteins not observed with Coomassie blue. However, this assumption
is questionable, for it is conceivable that phosphorylation is more common among lowabundance proteins. Ultimately, we cannot draw conclusions from this type of
comparison in terms of the proportion of the entire proteome that is modified by
phosphorylation.

2.3.2 Effects of Labeling Time on the Phosphoproteome Observed

Figure 7. Effect of labeling time. Comparison of the Chinese hamster ovary
phosphoproteome after (A) 4 h or (B) 16 h radiolabeling. Gels were exposed to the
phosphorscreen for equivalent times. Gray crosses indicate matched spots.
The extent of labeling significantly limits the detection of radiolabeled
phosphoproteins. We therefore examined the phosphoproteome observed using different
labeling times. It should be noted that no discernable changes in the Coomassie-stained
pattern were seen regardless of labeling time (data not shown). In a comparison between
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4 h and 16 h of 32P labeling (Figure 7), the longer labeling did allow detection of 22%
more 32P-labeled spots. However, the increased labeling time affected the number of

Figure 8. Spot intensities as a function of labeling time. Intensities of the 10 most intense
spots are seen to change with different labeling times. Spots are numbered according to
intensity as determined by the Melanie software.
spots as well as the relative intensities among spots. These two views of the
phosphoproteome can be meaningfully compared by matching only the more intense
spots (i.e., setting a high threshold for spot detection). When such a comparison was
made, only 71% of the spots correlated between the two phosphorimages. This indicates
that there are changes in the phosphoproteome pattern that are dependent on labeling,
although the overall pattern is similar. These changes can also be seen by comparing the
relative abundances of the 10 most intense spots from each of these two gel patterns
(Figure 8). If increasing the labeling time had the straightforward effect of only
increasing the signal of all phosphoproteins, then the relative intensities of the spots
common to these two views would be conserved. The fact that the relative intensities are
not conserved indicates that labeling time does not simply increase the sensitivity of the
labeling. We assume that the changes in the phosphoproteome with variation in labeling
time are due to the varied turnover rates of different phosphoproteins. Some proteins
might not have reached equilibrium in terms of labeling in the shorter labeling period,
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while others had. These kinetic considerations indicate that caution should be used in
interpreting intensities from radiolabeling experiments. Unless we can be sure that we are
at equilibrium conditions, we cannot be completely confident of relative stoichiometries
of labeling. Additionally, changes may be due to the prolonged exposure to the low
phosphate concentration in the media during labeling.

Figure 9. Effect of phosphatase inhibitor. Comparison of the Chinese hamster ovary
phosphoproteome labeled 4 h in the absence (A) and presence (B) of microcystin an
inhibitor of protein phosphatase type I and 2A. Spots labeled a-d show obvious changes;
Indicating that these proteins likely represent substrates for one of these phosphatases.

Figure 10. Spot intensities as a function of phosphatase inhibitor. Intensities of the 10
most intense spots change with microcystin (inhibitor of phosphatase I and 2A). Spots 110 are numbered according to intensity as determined by the Melanie software.
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2.3.3 Effect of a Specific Phosphatase Inhibitor
Stoichiometry of phosphorylation is often maximized by the inclusion of
phosphatase inhibitors during labeling. Additionally, information might be gained about
the substrates of particular phosphatases by comparing labeled proteins with and without
a specific inhibitor. We employed the inhibitor microcystin, which inhibits both type 1
and 2A protein phosphatases. As with varying labeling times, a good comparison can be
made by matching only the more intense spots (using a high threshold for spot detection).
Such a comparison was made between cells labeled in the presence or absence of
microcystin added during labeling (Figure 9). Although the overall phosphoproteome
pattern remains similar, 43% of the spots do not match. Obvious candidates for
phosphatase 1/2A dephosphorylation are the spots labeled a–d in Figure 5B. These and
more subtle changes can be seen when the 10 most intense spots from each gel are
compared (Figure 10).

2.3.4 Identifying Phosphoproteins from 2D gels
A goal of phosphoproteome analysis is the identification of the proteins that are
phosphorylated. Protein spots from 2D gels can be excised and the proteins identified
using in-gel digestion followed by MS. Eighteen gel pieces that represented matches
between spots on the Coomassie-stained gel and the phosphorimage shown in Figure 1
were selected as candidates to be identified and were cut out from the gel. These spots
were then digested in-gel and analyzed by oMALDI quadrupole-time of flight MS.
Fragmentation spectra (from collision-induced fragmentation) were submitted for
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identification by comparison to fragmentation patterns predicted from the National
Center for Biotechnology Information nonredundant database. Because of the
incompleteness of the sequence database for Chinese hamsters, we were unable to
identify several of the spots. Spots H, N, and Q were identified as the highly conserved
proteins listed in Table 1. One of these, hRNP K, is known to be a phosphoprotein
(Schullery et al., 1999). It is known that the pyruvate dehydrogenase E1 complex is
phosphorylated (Korotchkina et al., 1995), although we could not find in the literature if
the beta subunit has previously been determined to be phosphorylated. Because the
majority of the phosphoprotein spots were of such low abundance that they were not
observable by Coomassie stain, it is questionable whether or not identification of these
spots would be possible, even if working with samples from an organism whose genome
has been completely sequenced. Indeed, the correlation of the radioactive spots with
Coomassie-stained spots is only tentative, and it is possible that a phosphoprotein might
overlap on the gel with an abundant protein that is not phosphorylated but that would be
identified from the excised gel piece. Our results suggest that this method is not a
preferable method for identifying proteins that are phosphorylated.

Table 2. Identification of phosphoprotein spots cut from Coomassie-stained gel (Figure
5).
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2.3.5 Use of a Phosphoprotein Stain for Visualization
Because of the inconvenience of working with radioactive material, we decided to
investigate alternative ways of visualizing phosphoproteins after 2DE. We evaluated the
commercially available phosphoprotein fluorescence stain Pro-Q Diamond. Following
phosphor-specific staining, a fluorescent stain for total protein was employed. This
staining showed that the overall proteome was similar to that seen using Coomassie
(Figures 11A and B). We found that there is not perfect correlation between the

Figure 11. Comparison of radiolabeling and phosphoprotein staining for visualizing the
phosphoproteome. Similar regions are shown from (A) Coomassie-stained gel, (B) Sypro
Ruby stained gel, (C) phosphorimage of radiolabeled gel from A, and (D) Pro-Q
Diamond-stained gel (subsequently stained for total protein and shown in B).
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radiolabeled and Pro-Q Diamond-stained phosphoproteins (Figures 7C and D). The
differences could be due to aspects of the radiolabeling, such as favoring phosphoproteins
that experience rapid turnover. Alternatively, differences could be due to unequal staining
among phosphoproteins or lack of complete specificity of the phosphoprotein stain. A
further limitation to the use of this stain in many labs is that it serves only as a fair
phosphoprotein stain when laser-based gel scanning is not available as a visualization
method. Using transillumination as we did results in a lower-than-optimal signal-to-noise
ratio with the stain, and a higher limit of detection. However, we have no reason to
suspect that visualization using transillumination should affect the relative staining
intensities of the phosphoproteins that are detected.

2.4 CONCLUSIONS
Because radiolabeling of phosphoproteins is very sensitive and straightforward to
quantify, such analysis can give a clear picture of the relative phosphosphorylation of
proteins present in a sample. However, care must be taken to determine that the proteins
being labeled are in equilibrium with respect to the incorporation of label for this
quantitation to be meaningful. The radiolabel approach is accessible to most labs because
it does not require sophisticated instruments, although it does involve the inconvenience
of working with radioactive materials. Because of the limitations of 2DE and Coomassie
blue staining, many phosphoproteins cannot be visualized, especially low-abundance
proteins. Our results show that most phosphoproteins are low abundance, including some
of the most highly phosphorylated proteins. Furthermore, identification of
phosphoproteins from this approach is difficult because even if a spot is visible to be cut
out, it is not guaranteed that the protein identified is the radiolabeled protein seen to be
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phosphorylated. Although these methods do enable comparative profiling, they do not
allow facile identification of the phosphoproteins.
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CHAPTER THREE

NOVEL STRONG CATION EXCHANGE MONOLITHIC COLUMN
AND PHOSPHOPEPTIDE ISOLATION
This chapter is a modified version of a published paper [Gu et al., 2006]

3.1 INTRODUCTION
Strong cation exchange (SCX) is an extremely important mode of ion-exchange
chromatography for analyzing peptides and proteins (Mant et al., 1990). The utility of an
SCX column, which often contains sulfonate groups, lies in its ability to maintain
negative charge even under acidic buffer pH conditions (e.g., pH ~3). Under such
conditions, most peptides bear positive charge due to the presence of positively charged
basic residues (e.g., Arg, His, and Lys), terminal amino groups, uncharged acidic residues
(e.g., Glu and Asp), and terminal carboxyl groups. SCX chromatography is, therefore,
generally applicable for peptide analysis when operated in acidic buffer pH. On the other
hand, when the buffer pH is in the neutral pH range, SCX can only be applied to the
analysis of basic peptides or proteins.
In proteomics, the study of extreme complex protein and/or peptide mixtures
requires the use of multidimensional liquid chromtagraphy for separation prior to mass
spectrometry analysis. The technique called MudPIT (multidimensional protein
identification technology) was developed for this purpose. Rather than use traditional
two-dimensional gel electrophoresis, MudPIT separates peptides using two-dimensional
liquid chromatography, which usually uses an SCX column first, followed by a reversed-
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phased column before ionization (Chen et al., 2006; Cagney et al., 2005; Vitali et al.,
2005). The separation can be integrated directly with the MS ion source. An ideal SCX
column with high separation capacity and no hydrophobic interaction will greatly benefit
proteins identification by MS because of the high resolution of peptide/protein mixtures
and compatibility with the downstream of reversed mobile phase. One example of
MudPIT application is isolation of phosphopeptides using a SCX column (Beausoleil et
al., 2004) and then application of the isolated eluant to LC (reversed phase)-MS/MS for
large scale of identification phosphorylation sites. Most tryptic peptides usually have +2
charges at low pH (e.g. pH ~3). Attachment of one or more phosphate groups to peptides
(as in phosphopeptides) will lower the charge stages of the phosphopeptides. By taking
advantages of this property, phosphopeptides can be detached from other nonphosphopeptides. Of course there will be some phosphopeptides still in the +2 or more
charge stages when there are histidine residues in tryptic peptides.
Particle-based SCX columns received considerable interest for peptide analysis in
the 1980s because of the complementary selectivity to reversed-phase chromatography
(Mant et al., 1985a; Mant et al., 1985b; Alpert et al., 1988; Crimmins et al., 1988). For
example, the retention of peptides on a PolySulfoethyl A SCX column was found to be
monotonically related to the charge of the peptides (Alpert et al., 1988; Crimmins et al.,
1988). Several types of peptide standards were designed to evaluate three commercially
available SCX columns (Burke et al., 1989). They found that retention of peptides was
not only related to charge but also to peptide chain length. The retention of peptides was
empirically linearized under conditions in which hydrophobic interactions were
suppressed.
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Monolithic materials, termed “continuous polymer bed” (Hjerten et al., 1989)
offer an alternative to columns packed with small particles or beads. Excellent reviews
have appeared describing applications of polymer monoliths in liquid chromatography of
both small molecules and macromolecules (Svec et al., 2003; Svec et al., 2004a; Svec et
al., 2004b). In addition to polymer monoliths, silica monoliths in which a silica sol-gel
network is created by the gelation of a sol solution in a mold were introduced in 1996
(Fields et al., 1996; Minakuchi et al., 1996). Although silica monoliths are mechanically
more stable than polymer monoliths, the pH stability of silica is inferior and column
preparation requires multiple steps. In flow-through applications, such as
chromatography, the throughpores of the polymer monolith must be optimized to allow
passage of the mobile phase. Two methods have been developed for controlling the
throughpores. One is to adjust the monomer solution ionic strength to prepare an
acrylamide-based polymer monolith (Hjerten et al., 1999). The formation of throughpores
was achieved by the promoted hydrophobic interaction of the polymer backbone in the
presence of a high concentration of salt (e.g., ammonium sulfate). The other is to use
porogens. By a combination of good solvent, poor solvent, and/or linear polymer as
porogens, a broad range of medium throughpore diameters (500 nm-20 µm) can be
readily achieved (Svec et al., 2004a; Svec et al., 2004b). This strategy has been used
extensively and is a universal method to control the pore size distribution of a polymer
monolith. Using appropriate porogens, a variety of polymer monoliths have been
synthesized, e.g., based on acrylamide, acrylate, methacrylate, styrene, and norbornene
(Palm et al., 1997; Ngola et al., 2001; Svec et al., 1992; Petro et al., 1996; Gusev et al.,
1999; Premstaller et al., 2000) . Polymer monoliths have been extended to include SCX
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chromatography. To introduce sulfonate groups into the monolith backbone, several
approaches have been reported, including adsorption of surfactants (Paull et al., 2005;
Liu et al., 2002; Wu et al., 2001), grafting of a sulfonate-containing monomer (Rohr
2003; Viklund et al., 1997; Viklund et al., 2000), functionalization of a reactive monolith
with sodium sulfite (Ueki et al., 2004), and copolymerization (Palm et al., 1997; Ngola et
al., 2001; Peters et al., 1997; Peters et al., 1998; Zakaria et al., 2005; Hilder et al., 2004;
Wu et al., 2002). Among these, copolymerization is the most straightforward method
because it requires one step only and it is easy to control the amount of sulfonatecontaining monomer. For copolymerization, a sulfonate-containing monomer has been
copolymerized with a cross-linker in the presence or absence (Wu et al., 2002) of a bulk
monomer. Although direct copolymerization without the use of a bulk monomer is the
simplest, the only reported example was the copolymerization of 2-(sulfooxy)ethyl
methacrylate and ethylene glycol dimethacrylate for electrochromatography of peptides
(Wu et al., 2002) . However, due to the relatively low amount of 2-(sulfooxy)ethyl
methacrylate used in the monolith recipe (~17% total monomers), the resulting monolith
showed strong hydrophobicity. The separation of model peptides (2 or 3 residues)
exhibited reversed-phase rather than ion-exchange behavior. The lack of reports on direct
copolymerization of a sulfonate containing functional monomer with a cross-linker for
SCX mainly results from two reasons. First, a new optimization must be performed in
order to obtain a new polymer monolith although the composition of the monolith is
simpler. Second, a sulfonate-containing monolith is believed to swell excessively in
aqueous buffer (Ueki et al., 2004; Peters et al., 1997; Peters et al., 1998; Hilder et al.,
2004). Thus, the stability of a monolith composed of a high percentage of sulfonate-
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containing monomer is questionable. In this study, the preparation of a stable polymer
monolith by direct copolymerization of a high amount (40%) of 2-acrylamido-2-methyl1-propanesulfonic acid and poly(ethylene glycol) diacrylate was demonstrated for SCX
liquid chromatography of peptides for the first time. It was hoped that this new polymer
monolith could dramatically improve peak capacity of ion-exchange chromatography in
which ion exchange of peptides is often considered relatively slow and less efficient than
reversed-phase liquid chromatography for proteomics studies (Kimura et al., 2004).

3.2 MATERIALS AND METHODS
3.2.1 Chemicals and Reagents
2, 2-Dimethoxy-2-phenylacetophenone (DMPA, 99%), 3-(trimethoxysilyl)propyl
methacrylate (98%), 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS),
poly(ethylene glycol) diacrylate (PEGDA, Mn~258), and ethylene glycol dimethacrylate
(EDMA) were purchased from Sigma-Aldrich (Milwaukee, WI) and used without further
purification. Synthetic peptide standard CES-P0050 was obtained from Alberta Peptides
Institute (Edmonton, Alberta, Canada). Bradykinin fragment 1-7, peptide standard P2693,
and its nine components were from Sigma-Aldrich. Protein standards (myoglobin from
equine skeletal muscle, cytochrome c from bovine heart, and lysozyme from chicken egg
white) were also obtained from Sigma-Aldrich. Porogenic solvents for monolith synthesis
and chemicals for mobile-phase buffer preparation were HPLC or analytical reagent
grade.
For digestion of β-casein (Sigma-Aldrich), 1 mL of β-casein digestion solution,
which contained 50 µL of 1 M Tris pH 8.0 (99.9% purity, Fisher Scientific, Fair Lawn,
NJ), 10 µL of 0.1 M CaCl2 (EM Science, Cherry Hill, NJ), 20 µL of sequencing grade
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modified trypsin (Promega, Madison, WI), 100 µL of 2 mg/mL β -casein, and 820 µL of
MilliQ water, was incubated at 37 °C in a Shake’ N’ Bake hybridization oven (Boekel
Scientific, Feasterville, PA) overnight. The digest was quenched by acidifying with
formic acid. The β-casein digest was then desalted using a Strata-X 33 µm polymeric
sorbent column (Phenomenex, Torrance, CA), following the manufacturer’s protocol.
The eluent from the desalting column was lyophilized in a Centrivap cold trap (LabConco, Kansas City, MO), resuspended in 20 µL of gradient elution starting buffer, and
centrifuged using an Eppendorf centrifuge (Brinkmann, Westbury, NY) at 10 000 rpm for
3 min before injection.

3.2.2 Polymer Monolith Preparation
Before filling the UVtransparent capillary (75-µm i.d., 360-µm o.d., Polymicro
Technologies, Phoenix, AZ) with monomer solution, the capillary inner surface was
treated with 3-(trimethoxysilyl)propyl methacrylate to ensure covalent bonding of the
monolith to the capillary wall (Yu et al., 2001). The bulk monomer solution was prepared
in a 1-dram (4 mL) glass vial by mixing 0.008 g of DMPA, 0.32 g of AMPS, 0.48 g of
PEGDA, 0.20 g of water, 0.55 g of methanol, and 1.70 g of ethyl ether. The monomer
mixture was vortexed and ultrasonicated for 5 min to help dissolve AMPS and eliminate
oxygen. Because of its low viscosity, the monomer solution was introduced into the UVtransparent capillary by capillary surface action. The capillary (22-cm total length and
16.5-cm monolithic column length, unless otherwise specified) was then placed
perpendicular to a UV dichroic mirror from Navitar (Newport Beach, CA), which was
operated directly under a Dymax 5000AS UV curing lamp (Torrington, CT) for 3 min.
The resulting polymer monolith inside the capillary was connected to an HPLC pump and
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flushed with methanol and water sequentially to remove porogens and any unreacted
monomers. The prepared polymer monolith was then equilibrated with buffer solution
before use. Care was taken to avoid drying the monolith by storing it filled with water or
mobile phase. After completion of all chromatographic experiments, a small section (2
cm) of the monolith inside the capillary was dried under vacuum for scanning electron
microscopy (SEM) analysis (FEI Philips XL30 ESEM FEG, Hillsboro, OR) (Gu et al.,
2005). The same procedure was also applied to synthesize poly(AMPS-co-EDMA)
monoliths.

3.2.3 Capillary Liquid Chromatography (CLC)
CLC of peptides was performed using a system previously described, with some
modifications (Gu et al., 2005). Briefly, two ISCO model 100 DM syringe pumps with a
flow controller (Lincoln, NE) were used to generate a two-component mobile-phase
gradient. Due to the nanoliter per minute flow required for the monolithic capillary, the
gradient flow from the pump was split with the use of a Valco splitting tee (Houston,
TX), which was installed between the static mixer of the syringe pumps and the 60-nL
Valco internal loop sample injector. A 33-cm-long capillary (30-µm i.d.) was used as the
splitting capillary, and a 5-cm-long capillary (30-µm i.d.) was connected between the
splitting tee and the injector to minimize extracolumn dead volume. The mobile phase
flow rate was set at 69 µL/min. The actual flow rate in the monolithic capillary column
was measured by monitoring movement of a liquid meniscus through the 100-cm-long
open tubular capillary (75-µm i.d.), which was connected to the monolithic capillary
using a Teflon sleeve (Hamilton, Reno, NV). Depending on the mobile phase used, the
flow rate in the monolithic capillary was 70-100 nL/min, resulting in split ratios from
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700:1 to 1000:1. For CLC of peptides with gradient elution, mobile phase A was a 5 mM
phosphate buffer (pH 2.7 or 7.0) with various amounts of acetonitrile. Mobile phase B
was the same composition as mobile phase A plus 0.5 M NaCl, and a gradient rate of 15% B/min was typically used. All mobile phases were filtered through a 0.2 µm Nylon
membrane filter (Supelco, Bellefonte, PA) and ultrasonicated before use. The apparent
pH of the mobile phase was measured using a pH meter (Omego, Stamford, CT). Oncolumn UV detection was performed at 214 nm. Chromatograms were transferred to an
ASCII file and redrawn using Microcal Origin (Northampton, MA). The monolithic
column was also used for CLC of proteins using aqueous buffers. For measurement of the
dynamic binding capacity of the monolithic column, 1 mg/mL bradykinin fragment 1-7 in
5 mM phosphate containing 40% acetonitrile (pH 2.7) was pumped under constant
pressure of 2000 psi through the monolithic column (18.6 cm long, 75-µm i.d.) using one
syringe pump. No splitter was used for these measurements. Because of the low amount
(<1 mL) of the bradykinin fragment 1-7 solution available, it was preloaded into a sample
loop capillary (2 m long, 320-µm i.d.), with one end connected to the Valco injector and
the other end to the monolithic column using Upchurch unions (Oak Harbor, WA). The
flow rate was measured to be 91 nL/min. Following the same procedures, the dynamic
binding capacity based on uptake of protein (cytochrome c) was also performed on a new
monolithic column (7 cm long, 75-µm i.d.). A solution of 4 mg/mL cytochrome c in 5
mM phosphate (pH 6.2) was pumped through the column under constant pressure of 850
psi, resulting in a column flow rate of 91 nL/min. To study the swelling/shrinking
properties of the polymer monolith, different organic solvents were pumped through a
10-cm-long monolith segment inside a capillary at different pressures. A splitter and
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detector were not used for these measurements. The flow rate was measured as described
above.

3.2.4 Synthesis and Characterization of Acrylamidomethanesulfonic Acid
To the solution of 2-aminoethansulfonic acid (1.17 g, 10.5 mmol) in 10 mL of 1 N
sodium hydroxide, was added acryloyl choride (0.895 g, 10.0 mmol) and 3 N sodium
hydroxide separately at such a rate that the solution is always slightly alkaline while
stirring and cooling below 30°C with an iced-water bath. After the addition was
completed, the mixture was stirred for another 2 h. It was then poured into a 100 mL
beaker containing 3 mL of concentrated hydrochloric acid. The resulting precipitates
were collected by suction filtration, washed with cold water, dried and recrystallized from
ethanol-water.
The resulting product was dissolved in 100% methanol and analyzed using an LCMSD-TOF (Agilent technologies, Santa Clara, CA) with a mobile phase of 75%
methanol, 25% miliQ H2O, and 5 mM ammonium formate. All columns were by-passed
and the sample was directly introduced into the MSD-TOF detector.

3.2.5 Safety Considerations
AMPS monomer is listed as a suspected carcinogen, and PEGDA is a sensitizing
agent. Appropriate MSDS information should be consulted for physical handling of these
materials. Sunglasses that block UV light and gloves should be worn to avoid sunburns
caused by the high-power UV-curing system during the preparation of the monolith.
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3.3 RESULTS AND DISCUSSION
3.3.1 Polymer Monolith Preparation
AMPS, a commercially available acrylamido derivative, was chosen as monomer
to synthesize the SCX monolithic column because it contains the desirable sulfonate
group. PEGDA, which is an acrylate based cross-linker with three ethylene glycol units,
has been shown to resist adsorption of peptides and proteins (Gu et al., 2005). Therefore,
it was selected as cross-linker for the synthesis of the monolith. PEGDA was used instead
of EDMA as cross-linker to prepare a monolith with more hydrophilicity. The most
widely used porogen strategy was adopted to control the throughpores in the monoliths in
this study. To date, choice of porogens has been mainly achieved by trial and error,
although some theoretical aspects for porogen selection have been derived for
macroporous particle synthesis using suspension polymerization (Guyot et al., 1982;
Sederel et al., 1973; Kun et al., 1968). Because the solubility of AMPS in common
organic solvents is low, water was selected as one of the porogens to help dissolve
AMPS. Methanol was selected as another porogen because it was proven efficient for the
formation of macroporous throughpores in a poly(PEGDA) monolith (Gu et al., 2005).
Unfortunately, any combination of water and methanol (with 0.32 g of AMPS and 0.48 g
of PEGDA) yielded a nonporous or microporous translucent gel structure that allowed no
flow of mobile phase. The same results were also observed for combination of water,
methanol, and 1-propanol. Since ethyl ether is another powerful porogen for PEG-based
monoliths, it was finally chosen as the third porogen. After simple optimization, a recipe
(25% monomers, composed of 40:60 wt % AMPS and PEGDA, and 75% porogens,
composed of 8:23:69 wt % water, methanol, and ethyl ether) was finalized, and the
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resulting monolith supported considerable flow under moderate pressure in aqueous
buffer. Noteworthy was the incorporation of 40% AMPS, which represents the highest
reported percentage of AMPS copolymerized into a polymer monolith backbone. Due to
the one-step in situ synthesis protocol, the rate of success in preparing such monolithic
capillary columns approached 100%. A scanning electron micrograph of the optimized
monolith is shown in Figures 12A and B. It can be immediately observed that the
morphology of the poly(AMPS-co-PEGDA) monolith is unique. It was composed of
fused microglobules, with no distinct microspheres. It appeared intermediate between a
conventional polymer monolith with a distinct particulate structure (Svec et al., 2003;
Svec et al., 2004) and a silica monolith with a skeletal structure (Fields et al., 1996;
Minakuchi et al., 1996). The throughpores of the monolith were obvious. Cracks along
the circumference of the monolith (Figure 12A) were presumably due to shrinking of the
monolith upon drying when SEM images were taken.
To explore variables that could result in the formation of this unique morphology,
two other monoliths were prepared and their SEM photographs are shown in Figures 12C
and D. With an increase in methanol in the porogen composition, conventional polymer
monolithic morphology with discrete and more “regular” microglobules was formed
(Figure 12C). If EDMA was used as crosslinker, the resulting poly(AMPS-co-EDMA)
monolith exhibited similar fused but more porous structure (compare Figures 12B and
D). Based on these micrographs, it seems that porogens rich in methanol or the use of
EDMA as cross-linker favored the formation of conventional polymer monolithic
morphology, while a monolith formed from porogens rich in ethyl ether or that used
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PEGDA as cross-linker tended to form a fused structure. Both porogen and crosslinkerare important factors that control the morphology of poly(AMPS) monoliths.
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Figure 12. SEM photographs of several monoliths synthesized. (A) Optimized
poly(AMPS-co-PEGDA) monolith used in this study (scale bar, 20 µm); (B) higher
magnification of the monolith in (A) (scale bar, 2 µm); (C) poly(AMPS-co-PEGDA)
monolith that has the same composition as (A) except that methanol and ethyl ether were
0.85 and 1.40 g, respectively (scale bar, 2 µm); (D) poly(AMPS-co-EDMA) monolith
(recipe: 0.008 g of DMPA, 0.35 g of AMPS, 0.40 g of EDMA, 0.35 g of water, 1.10 g of
methanol; scale bar, 2 µm).
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3.3.2 Effect of Acetonitrile on the Elution of Synthetic Peptides.
An ideal SCX column for LC of peptides should be moderately hydrophilic, be
able to retain weakly charged analytes (e.g., +1 charged peptides), and exhibit retention
of analytes independent of buffer pH from acidic to neutral (Burke et al., 1989). In
addition, high binding capacity is another favorable feature, which improves peptide
resolution. Several synthetic peptides were designed to evaluate particle-based SCX
columns (Burke et al., 1989; Mant et al., 1991). The synthetic peptide standard,
CESP0050, was composed of four peptides (see Table 3), which possess certain
characteristics for SCX column evaluation. These peptides are all undecapeptides having
chain lengths similar to those most commonly encountered in protein tryptic digests, and
they do not have any acidic residues (the C-terminal groups are amides), so they possess
the same charges in acidic to neutral buffers. The hydrophobicity index of these peptide

Table 3. Properties of Synthetic Peptides.
standards has been compiled for pH 7.0 (Mant et al., 1991). However, they were retabulated in
Table 3 for easy reference, along with other properties (e.g., amino acid sequence).
Figure 13 shows a gradient elution chromatogram of the synthetic peptides under different
buffer conditions using the poly(AMPS-co-PEGDA) monolithic SCX column. With an increase
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in acetonitrile in the mobile phase from 0 to 40% (see Figure 13A-E), the elution times for
peptides 1-4 were monotonically decreased. For peptide 4, addition of 40%

Figure 13. SCX chromatography of synthetic peptides. Conditions: 16.5 cm x 75 µm i.d.
monolithic column; buffer A was 5 mM NaH2PO4 (pH 2.7) and buffer B was buffer A
plus 0.5 M NaCl, both buffers containing 0, 10, 20, 30, or 40% (v/v) acetonitrile (panels
A-E, respectively); 2-min isocratic elution of 1% B, followed by a linear AB gradient
(5% B/min, equating to 25 mM salt/min) to 100% B and various times of isocratic elution
of 100% B until peptide 4 was eluted; ~10 min gradient delay time; mixture of peptides
1-4 (see Table 3 for sequence) in CES-P0050, which was dissolved in 400 µL of buffer A
with 0% acetonitrile, resulting in a concentration of 0.44 mM for peptide 3; 69 µL/min
pump master flow rate; 76, 83, 85, 89 or 100 nL/min column flow rates (panels A-E,
respectively); online UV detection at 214 nm.
acetonitrile in the elution buffer was required to suppress hydrophobic interactions
(compare Figures 13D and E). For the less hydrophobic peptides 2 and 3, 20-30%
acetonitrile could effectively eliminate hydrophobic interactions, as evidenced by the
very sharp peaks obtained. For the least hydrophobic peptide 1, no acetonitrile was
required because no significant hydrophobic interactions were observed. The minor
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differences in retention times for peptide 1 were likely due to differences in mobile-phase
column flow rate. The dramatic decrease in retention time and improvement in peak
shape for peptide 4 indicates relatively strong hydrophobicity of the poly(AMPS-coPEGDA) monolith. This feature is not desirable for two dimensional LC (e.g., ion
exchange followed by reversed phase) for proteomics, in which an aqueous buffer
without acetonitrile is required in the first dimension to effect retention of peptides in the
second dimension before separation. The relatively strong hydrophobicity of the
poly(AMPS-co-PEGDA) monolith was surprising.
The biocompatible cross-linker PEGDA was specially designed and used to
decrease unwanted polymer backbone hydrophobicity. To further confirm the
biocompatibility of PEGDA, a poly(PEGDA) monolith was prepared following a
previously published protocol (Gu et al., 2005), and peptides 1-4 were eluted from the
monolith using buffers containing various amounts (0-40%) of acetonitrile. Results (data
not shown) indicated negligible differences in peptide elution with the use of different
buffers. Therefore, the relatively strong hydrophobicity of the poly(AMPS-co-PEGDA)
monolith must be due to the monomer AMPS itself. In fact, the AMPS molecule contains
an isobutyl arm, which connects the sulfonate group on one end and the acrylamido
group on the other end was found that Poly-Sulfoethyl A columns were superior to the
more hydrophobic sulfopropyl columns (Alpert et al., 1988). By analogy, it is expected
that the monolithic sulfobutyl phase possesses stronger hydrophobicity than desired due
to the butyl segment in the side groups. Despite the strong hydrophobicity of the
poly(AMPS-co-PEGDA) monolith, it was shown to retain strongly the +1 charged
peptide (see Figure 13E). This positive feature is uncommon for commercially available
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particulate SCX columns where only the PolySulfoethyl A column could retain the
peptide (Burke et al., 1989; Mant et al., 1991). For 40% acetonitrile, where any
hydrophobic interaction was greatly eliminated, retention of the peptide on the monolith
would be expected from ionic interaction only. This strong ionic interaction can be
attributed to the use of a high amount of AMPS (40%) in the copolymerization. With
hydrophobic interactions suppressed (i.e., with the use of 40% acetonitrile), the four
synthetic peptides were eluted as extremely sharp peaks (see Figure 13E), with an
average peak width at baseline of 0.28 min. According to the simple definition of peak
capacity in gradient elution (peak capacity = time of gradient/peak width) (Stadalius et
al., 1985), the peak capacity was calculated to be 71, a value surpassing most particulate
based SCX columns (Burke et al., 1989; Mant et al., 1985; Alpert et al., 1988) (Peak
capacities of 24-66 were estimated based on several chromatograms provided in these
references) and other polymer monolithic SCX columns (Hjerten et al., 1989; Viklund et
al., 1997; Ueki, et al., 2004) [Peak capacities of 5-32 were again estimated; in the case of
isocratic elution, the peak capacity was calculated as n=((N)1/2/4) ln(t2/t1), where N is the
column efficiency and t2 and t1 are the retention times of the last and the first eluting
peaks, respectively]. The asymmetry factors calculated at 10% peak height for peptides 14 were 1.01, 0.94, 0.90, and 0.99, respectively. The sharp peaks together with minimal
fronting or tailing indicated a highly efficient SCX monolithic column. The run-to-run
reproducibility of the poly (AMPS-co-PEGDA) column was good. For three consecutive
runs using conditions the same as in Figure 13E, the relative standard deviation (RSD) of
the retention times for peptides 1-4 were 1.9, 0.7, 0.3, and 0.4%, respectively. For peak
height, the RSD values for peptides 1-4 were 4.6, 2.3, 2.0, and 1.7%, respectively. These
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data clearly demonstrate that good reproducibility could be readily achieved if the
column was equilibrated with starting buffer for a sufficient period (typically ~10 column
volumes) between runs, although the polymer monolith exhibited swelling in aqueous
buffers (vide infra). Column-to-column reproducibility measurements gave retention time
RSD values (n= 3) for peptides 1-4 of 1.3, 1.6, 2.2, and 2.4%, respectively. However,
significant deviation was observed for peak height measurements; the RSD values for
peptides 1-4 were 18.5, 18.6, 34.6, and 21.9%, respectively.

3.3.3 Effect of Buffer pH on the Resolution of Synthetic Peptides
With an increase in buffer pH from 2.7 to 7.0, greater retention with similar sharp
peaks was observed for synthetic peptides 1-4 under otherwise identical conditions as in
Figure 13E (data not shown). Because the peptides bear the same charges in both buffer
pHs (see Table 3), this indicates an increased negative charge density of the monolith
upon an increase in buffer pH. Although AMPS is a strong organic acid with pKa of 1.2
(Righetti et al., 1990), the pKa of poly(AMPS) shifts to a higher value due to the absence
of electron-withdrawing vinyl groups upon polymerization (Issa et al., 2003). An increase
in metal-poly(AMPS) retention was observed with an increase in buffer pH from 1 to 7
(Rivas et al., 2001). Thus, the lower acidity of poly(AMPS) over AMPS accounts
primarily for the increased retention of peptides at pH 7.0 compared to pH 2.7. Another
contributing factor is the presence of acrylic acid, an impurity found in both AMPS and
PEGDA monomers, which can be copolymerized into the monolith backbone. However,
no confirmation of this was sought. The stronger retention of peptides upon increase of
buffer pH was also observed for most particulate based SCX columns (Burke et al.,
1989).
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3.3.4 Dynamic Binding Capacity
One of the most important properties of an ion-exchange column is the binding
capacity (Haddad et al., 1990), which determines the resolution, column loadability, and
gradient elution strength. For the measurement of dynamic binding capacity of an SCX
column, proteins (e.g., lysozyme or hemoglobin) are often used. Although the monolithic
column could elute and separate proteins using buffers with high ionic strength (vide
infra), it did not elute lysozyme, cytochrome c, or hemoglobin within 2 h under
conditions typical for SCX chromatography of peptides [e.g., 5 mM phosphate (pH 2.7)
containing 40% acetonitrile and 0.5 M NaCl]. Therefore, bradykinin fragment 1-7, which
bears a +2 charge at pH 2.7, was used to determine the monolithic column dynamic
binding capacity. During frontal analysis, a sharp increase in baseline was observed,
indicating fast kinetic interaction of the peptide with the column. With the use of 1
mg/mL peptide, it took an amazingly long time (1074 min) to saturate the column. Based
on the measured flow rate of 91 nL/min, the dynamic binding capacity was 119 mg/mL,
corresponding to 157 µequiv/mL. From the monolith recipe (see Experimental Section),
this 40% MPS/60% PEGDA monolith had a theoretical binding capacity of 475
µequiv/mL. This indicates that about 33% of AMPS in the monolith backbone was
accessible for ionic interaction. The major portion (67% in this case) of AMPS is most
likely buried in the polymer monolith, due to the direct copolymerization method used.
Nevertheless, the dynamic binding capacity of the poly(AMPS-co-PEGDA) monolith
was high. This was supported by the elution of the +4 charged peptide 4 as shown in
Figure 13E after a 20-min gradient step.
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For simple comparison with other SCX columns, the dynamic binding capacity
was also measured based on cytochrome c uptake although such measurement might be
inappropriate and inaccurate due to hydrophobic binding. It took 282 min to saturate the
7-cm-long monolith, resulting in a binding capacity of 332 mg/mL. The dynamic binding
capacity of our monolith was compared with other columns. The PolySulfoethyl A
column had a dynamic binding capacity of 100 mg of hemoglobin/mL of packing
material, corresponding to ~3 µequiv/mL (Alpert et al., 1988). Because 157 µequiv of
peptide/mL or 332 mg of protein/mL was achieved for the current monolithic column, the
binding capacity was greater than that of the PolySulfoethyl A column. For the
poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate) monoliths (Viklund et al.,
1997; Viklund et al., 2000) grafted with AMPS for SCX chromatography of proteins, the
dynamic binding capacity was found to be typically lower than 100 mg of protein/g of
monolith. For the functionalized poly(glycidyl methacrylate-co-ethylene glycol
dimethacrylate) monolith (Ueki et al., 2004), the dynamic binding capacity was 90-300
µequiv/mL, albeit based on copper ion uptake. The binding capacity was very low (~1
µequiv/mL) for the anion-exchange polymer monolith (Zakaria et al., 2005), which was
prepared by agglomeration of aminated latex particles to a monolith prepared through the
copolymerization of a small amount of AMPS, a large amount of butyl methacrylate, and
EDMA. This was presumably due to the lower amount of AMPS used in the
copolymerization. In summary, the dynamic binding capacity of the current monolith,
which was prepared from direct copolymerization of 40% AMPS and 60% PEGDA, was
greater than the particulate-based SCX PolySulfoethyl A column and most of the other
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polymer monolithic SCX columns.

Table 4. Properties of the Nine Peptides in the P2693 Standard.

3.3.5 SCX Chromatography of a Complex Peptide Mixture
To demonstrate the general utility of the poly(AMPS-co-PEGDA) monolith for peptide
analysis, a more complex peptide mixture P2693 composed of nine natural peptides (see
Table 4) was chromatographed using buffer containing 40% acetonitrile under different
gradient rates (Figure 14). As seen in Figure 14A, seven out of the nine peptides were
resolved when 5% B/min gradient rate was used. By decreasing the gradient rate to 2%
B/min, eight peaks were baseline separated (Figure 14B). A further decrease in the
gradient rate to 1% B/min resolved all nine peptides, although peptides 2 and 3 were not
baseline separated (Figure 14C and inset). Thus, it is convenient to use a shallow gradient
to improve resolution for analyzing complex samples. The separation shown in Figure
14C was governed by an ion-exchange mechanism. Following the empirical relationship
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Figure 14. SCX chromatography of natural peptides. Conditions were the same as those
in Figure 13E with the following exceptions: mixture of nine natural peptides (see Table
4) dissolved in 25 µL of buffer A to make each peptide ~1 mg/mL; gradient rate of (A) 5,
(B) 2, and (C) 1% B/min.
between retention time and charge-to-chain length ratio (Burke et al., 1989), a straight
line [tR ) 66.03N/ln(n) - 2.05] was obtained with a regression coefficient of 0.96, where tR
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is the peptide retention time, N is the charge, and n is the number of amino acid residues.
This confirmed a pure ionic interaction of the polymer monolith for SCX of natural
peptides with 5-14 residues and a hydrophobicity range from 7.5 to 34.9 (see Table 4). It
is interesting that the elution order in Figure 14C is the reverse of that in capillary zone
electrophoresis (CE) (cf. technical bulletin for P2693 from Sigma,
http://www.sigmaaldrich.com/ sigma/datasheet/p2693dat.pdf) except for peptides 7 and
8. This is not unexpected because retention in SCX is based on the charge-to-ln(chain
length) ratio, while in CE migration is determined by analyte charge-to-size ratio. Thus,
an analyte with more charge and smaller size will migrate earlier in CE and elute later in
SCX. As compared with separation in CE, better resolution (with the exception of
peptides 2 and 3) was generally obtained for SCX chromatography, although longer time
was required. Peak widths were somewhat narrower in SCX chromatography than in CE.
This demonstrates that comparable or better resolution and efficiency was achieved for
peptide analysis with the use of the poly(AMPS-co-PEGDA) monolithic column than for
CE. The average peak width at baseline in Figure 14A (excluding the second peak due to
coelution of three peptides), Figure 14B (excluding the second peak due to coelution of
two peptides), and Figure 14C (excluding the second and third peaks due to incomplete
resolution) were 0.27, 0.38, and 0.56 min, resulting in peak capacities of 74, 130, and 179
for the gradient rates of 5, 2, and 1% B/min, respectively. As discussed above, the peak
capacity calculated from Figure 13E was 71, where a gradient rate of 5% B/min was used
for SCX of four synthetic peptides. It seems that the peak capacity depends on the salt
gradient rate and not on the analytes used. A shallower gradient resulted in a greater peak
capacity. This was due to the use of the unique monolith, for which the peak width
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increased less proportionally upon an increase in the gradient elution time. This feature is
attractive for resolving complex peptide samples (e.g., protein digests). Noteworthy was
the resolution between methionine enkephalin and leucine enkephalin (inset in Figure
14C). These two peptides bear the same charge and have the same chain length (see
Table 4). They also have very similar molecular weight and hydrophobicity. Due to the
use of 40% acetonitrile in the mobile phase, it is not likely that the resolution was based
on differences in hydrophobicity. Instead, the separation was primarily due to differences
in ionic interaction resulting from a minor difference in molecular weight. Because
methionine enkephalin has a greater molecular weight than leucine enkephalin, the ionic
interaction between methionine enkephalin and the monolith would be expected to be
somewhat smaller, leading to earlier elution. The successful separation of methionine
enkephalin and leucine enkephalin emphasizes the exceptional resolution provided by the
poly(AMPS-co-PEGDA) monolith. Further evaluation of the monolith was conducted for
SCX chromatography of a β-casein digest (Figure 15). Once again, very nice separation
was obtained. Based on several completely resolved peaks (indicated in Figure 15), the
peak capacity was estimated to be 167, close to 179 measured using peptide standard
P2693. This confirmed that peak capacity was not dependent on the sample analyzed, but
on the gradient rate. It should be mentioned that the protein digest had to be desalted. If
the β-casein digest was not desalted (see Experimental Section), the peptides coeluted in
15 min (data not shown). This is expected because peptides will not be strongly retained
if they are dissolved in a high concentration of salt buffer. During the experiment, it was
also important to use freshly prepared peptides and to store them in a refrigerator. For
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Figure 15. SCX chromatography of a β-casein digest. Conditions were the same as in
Figure 14C.

Figure 16. SCX chromatography of an old synthetic peptide sample. Conditions were the
same as in Figure 13E.
example, peptide standard CES-P0050 degraded if dissolved in the starting buffer and
stored at 2-8 °C for more than 2 months. Figure 16 shows a separation of a degraded
sample. In addition to the main four peptides, eight other peptides could be clearly seen.
This, once again, demonstrates the high resolution of the poly(AMPS-co-PEGDA)
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monolith for SCX liquid chromatography of peptides. It opens the possibility of using
SCX chromatography for quality analysis (e.g., purity) of peptides, although such
analyses are almost exclusively performed using reversed-phase liquid chromatography.

3.3.6 SCX Chromatography of Protein Standards
An attempt was also made to perform SCX chromatography of basic proteins, and
the result is shown in Figure 17. As mentioned before, proteins did not elute from the
monolithic column when 5 mM phosphate (pH 2.7) containing 40% acetonitrile and 0.5
M NaCl was used as eluent. This is likely due to stronger binding of proteins than
peptides, as confirmed by the elution of proteins when NaCl concentration was increased
to 2.0 M. However, due to the poor solubility of NaCl in 40% acetonitrile, a buffer that

Figure 17. SCX chromatography of proteins. Conditions were the same as in Figure 13E
except that different buffers were used; buffer A was 5 mM phosphate (pH 6.2) and
buffer B was buffer A plus 2.0 M NaCl. Analytes: (1) myoglobin, (2) cytochrome c, and
(3) lysozyme. The baseline drift during gradient elution and the rise of the baseline at the
end of the gradient were due to the difference in UV absorbances of buffers A and B.
contains no acetonitrile must be used. Thus, the separation in Figure 17 was based on a
mixed-mode mechanism. An increase in buffer salt concentration resulted in a decrease
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in ionic interaction and an increase in hydrophobic interaction. As a result, protein peaks
were broadened by the increased nonspecific hydrophobic interaction during salt gradient
elution. Although the SCX column exhibited worse chromatographic performance for
proteins than for peptides, it was comparable to other monolithic SCX columns for
protein analysis (Viklund et al., 1997).

3.3.7 SCX Chromatography Application for the Separation of Model
Phosphopeptides
A mixture of one tryptic phosphopeptide and two other non-phosphopeptides was
used as a model to show the utility of this column in isolation of phosphopeptides from
non-phosphopeptides. Even under isobaric buffer B, the +1 charged phosphopeptide (Et
=4.20 min in Figure 18) is well separated from the other two non-phosphopeptides (Et =
7.11 and 12.25 min, respectively, for +2 and +3 non-phosphopeptides in Figure 18).

3.3.8 Stability of the Poly(AMPS-co-PEGDA) Monolith
Permeability is a good index to reflect swelling or shrinking of the monolith. If a
monolith swells, its throughpores will decrease in size, resulting in lower permeability,
and vice versa. From Table 5 the permeability was ~1 order of magnitude lower in
aqueous buffer than in some organic solvents. With the use of organic solvents, the
permeability decreased roughly with an increase in solvent relative polarity, except that
ethyl ether and acetone had the highest permeability. This indicates that the monolith
swells in more polar solvents and shrinks in less polar solvents. Although the
poly(AMPS-co-PEGDA) monolith swelled in aqueous buffer and shrank in organic
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Figure 18. SCX chromatography of a phosphopeptide and a mixture of three peptides.
Isocratic Buffer B was used to separate the real peptides (bule chromatogram) 60 nL of 2
mg/mL monophosphopeptide from β-casein (T6) was loaded, the retention time for this
+1 charged peptide is 4.20 min (red chromatogram) 60 nL of a mixture of three peptides
monophosphopeptide (+1), bradykinin fragment 1-7 (+2) and angiotensin fragment 1-7
(+3) at 1 mg/mL was loaded. The retention times are 4.32 min, 7.11 min and 12.25 min
for T6, bradykinin fragement 1-7, and angiotensin fragment 1-7, respectively.
solvents, no detachment of the monolith from the capillary wall was observed under any
condition, likely due to covalent attachment to the capillary wall. Furthermore, the
column flow rate reached a constant value after equilibration with a new solvent. This
indicated reversible shrinking or swelling of the monolith under a variety of solvent
conditions. For the SCX liquid chromatography of peptides reported in this study, the
column flow rate measured was 70-100 nL/min when the back pressure read from the
pump panel was between 2000 and 2300 psi during the gradient run. This indicates that a
considerable flow was generated at moderate pressure even though the monolith swelled.
The polymer monolith could be used continuously over 1 month under a pressure of
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Table 5. Permeability of the Poly(AMPS-co-PEGDA) Monolith
2000 psi. Excessive swelling of the sulfonate-containing polymer monolith in aqueous
buffer, which would result in no flow, was not observed for the poly(AMPS-co-PEGDA)
monolith reported in this study.

3.3.9 Tentative Explanation of the Sharp Peaks Obtained
It is interesting that the permeabilities of the monolith in aqueous buffers A and B
were different (see Table 5). An increase in permeability was observed with the use of the
same buffer with 0.5 M NaCl additive. This reflects a responsive property of the
poly(AMPS-co-PEGDA) monolith upon contact with salt. Poly(trimethylolpropane
trimethacrylate) monolith [poly(TRIM)] with a surface grafted with N, N-dimethyl- Nmethacryloxyethyl-N-(3-sulfopropyl) ammonium betaine (SPE) showed a salt-dependent
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permeability (Viklund et al., 2000). However, the permeability decreased with an
increase in NaCl concentration in the range of 0-0.2 M. Interestingly, no such trend was
observed for the monolith prepared by copolymerization of TRIM and SPE. The saltdependent permeability of the poly (AMPS-co-PEGDA) monolith is expected to have an
influence on the chromatography of peptides. The mobile phase flow rate in the
monolithic column increased in our system during the salt gradient run because the
nanoflow gradient in the column was generated by a passive splitter (see Experimental
Section). As seen in Figure 14, the sharper the salt gradient, the narrower the peak
widths. Double gradient elution was previously demonstrated in ion-exchange liquid
chromatography of small ions, where a flow gradient was intentionally employed to
achieve fast separation (Paull et al., 2005). It should be emphasized that although a
natural flow rate gradient existed in these studies, it did not contribute significantly to the
sharpening of peptide bands, especially under shallow (e.g., 1% B/min) salt gradient
conditions, where a flow rate increase of ~1.4 times (see Table 5) was estimated for a
100-min interval. It is hypothesized that the extremely sharp peaks achieved in this study
are primarily due to the nature of the poly(AMPS-co-PEGDA) monolith. While the
poly(AMPS-co-PEGDA) monolith was shown to exhibit strong hydrophobicity, the
hydrophobicity was mainly derived from the side chains of the monolith that attached the
functional AMPS monomer. The backbone of the polymer monolith contributed
negligible hydrophobicity due to the use of both a biocompatible cross-linker PEGDA
and a biocompatible acrylamido group in the AMPS. Thus, no nonspecific hydrophobic
interaction between the polymer backbone and peptide would occur. Because the side
chains are located on the surface of the polymer monolith upon contact with aqueous
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buffer, mass-transfer resistance would be small, resulting in high column efficiency. To
test this hypothesis, SCX chromatography of synthetic peptides 1-4 on a poly(AMPS-coEDMA) monolith was performed under the same conditions as in Figure 13E. Although
well separated, the peaks for all four peptides were broad and tailing (data not shown).
This observation confirms that the extremely narrow peaks obtained in this study were
primarily due to the use of the biocompatible cross-linker PEGDA.

3.3.10 Synthesis of Acrylamidomethanesulfonic Acid

Figure 19. LC-MSD-TOF confirmation of acrylamidomethanesulfonic acid. The reaction
mixture (0.1 g) was dissolved in methanol. The sample was carried directly to TOF
detector without any chromatographic separation.
The desired product, acrylamidomethanesulfonic acid, was confirmed by LC-MS
detection of peak 187.9997 Da, which is the [M+Na]+ ion (M+ refers to +1 charged
molecular ion). It was 1.34 ppm error to the theoretical molecular weight value (187.9988
Da). In order to obtain a quantitative ratio of product acrylamidomethanesulfonic acid
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and reactant 2-aminoethansulfonic acid, the resulting reaction mixture was also dissolved
in D2O and analyzed using 500MHz NMR. The ratio of desired produce/reactant (2aminoethansulfonic acid) is about 1:3 (data not shown). Due to the similarity of the two
molecules, I have not been able to separate them from each other so as to achieve a pure
acrylamidomethanesulfornic acid monomer.

3.4 CONCLUSIONS
A poly(AMPS-co-PEGDA) monolith containing as high as 40% AMPS was
prepared by one-step copolymerization. The monolith had several favorable features,
such as high binding capacity, extraordinary high resolution, and high peak capacity,
making it ideal for resolving complex peptide samples, such as protein digests. Due to its
excellent chromatographic performance and ease of preparation, the poly(AMPS-coPEGDA) monolith is expected to find many applications. A unique structural feature of
the new monolith is the use of PEGDA instead of the conventional EDMA cross-linker,
which is believed to result in the high resolution and sharp peaks obtained for peptide
analysis. Due to the hydrophobicity of the AMPS monomer, a better monolith could be
obtained if a more hydrophilic functional monomer was used. For example, if
acrylamidomethanesulfonic acid or 2-acrylamido-1-ethanesulfonic acid was used in place
of AMPS, the hydrophobicity of the resulting monolith would be dramatically decreased.
This should, in turn, provide even better separation of peptides and make efficient SCX
of proteins possible with aqueous buffers containing no acetonitrile. Unfortunately,
neither of the two monomers is commercially available. The syntheis
acrylamidomethanesulfonic acid was carried out. Analysis of confirmed the formation of
the desired product by both the molecular weight (by LC-MS) and structure (by NMR). It
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is hard to purify the product from the reaction mixture because of the similarity between
the reactant (2-aminoethansulfonic acid) and the product (acrylamidomethanesulfonic
acid). Another possible alternative functional monomer is the commercially available
vinylsulfonic acid. Unfortunately, it may be challenging to design suitable porogens to
copolymerize vinylsulfonic acid and PEGDA because it is well known that the
polymerization rate of vinyl and acrylamido groups is different. Another difficulty is the
unavailability of pure vinylsulfonic acid. For example, sodium vinylsulfonate, a sodium
salt of vinylsulfonic acid, is available through Sigma as ~30% solution in H2O. This
further complicates the porogen design because the ratio of vinylsulfonic acid to water is
fixed at 3 to 7 if 30% sodium vinylsulfonate is used.
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CHAPTER FOUR

ANALYSIS OF PHOSPHORYLATION OF SYNTAXIN 1A AND 4A BY AMPK

4.1 INTRODUCTION
In large scale phosphoproteome studies, the goal is to identify as many
phosphorylation sites from as many phosphoproteins as possible. So far, only a subset of
a phosphoproteome can be observed due to limitations mentioned in the introduction.
Furthermore not every single phosphorylation site can be identified in this type of study.
When examining a single phosphorylated protein, different strategies should be applied
for different phosphorylation scenarios, depending on conditions such as the
phosphorylation stoichiometry, the availability of proteins and instrumental conditions.
All means should be applied to the study because, for any single protein, no one method
ensures success. All our phosphorylation studies employed a Qstar Pulsar I (Applied
Biosystems, Foster City, CA) triple quadrupole-time-of-flight mass spectrometer.
Usually, information-dependent acquisition (IDA) was used to collect MS/MS spectra.
Phosphopeptides, due to poor stoichiometry and/or low ionization in the positive mode,
are seldomly automatically chosen for fragmentation. Even when they are, their
fragmentation spectra are usually not adequate for phosphorylation site identification
purposes. In this chapter, enrichment of phosphopeptides by TiO2 resins was used to
study a quadruply phosphorylated peptide from phosducin-like protein (PhLP), and
peptide-level mapping was used to study the phosphorylation of syntaxin 1a.
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Protein phosphorylation plays a major role in signal transduction. The work
undertaken here involved the phosphorylation of syntaxins by AMPK (AMP-activated
protein kinase). AMPK serves as an energy sensor and metabolic switch in cells by
phosphorylating key target proteins that control flux through metabolic pathways of
hepatic ketogenesis, cholesterol synthesis, lipogenesis, triglyceride synthesis, adipocyte
lipolysis, and skeletal muscle fatty acid oxidation. It has been also shown that AMPK was
activated (Vavvas et al., 1997; Winder et al., 1996) and glucose uptake was increased
(Goodyear et al., 1998; Hayashi et al., 1997; Holloszy et al., 1996) under muscle
contraction. Glucose uptake, which is part of the effect of insulin, was shown to be
increased by chemical activation of AMPK (Hayashi et al., 1998). Winder et al proposed
a novel mechanism for stimulation of glucose uptake in skeletal muscle under muscle
contraction as shown in Figure 20 (Winder et al., 1999). Briefly, muscle contraction
activates AMPK, which stimulates glucose uptake through the phosphorylation of one or
more SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment protein
receptor) proteins involved in the vesicle membrane fusion process by AMPK.
The AMPK substrate(s) that are responsible for the increased fusion of
microvesicles to the membrane have not been identified yet. An examination of the
elements involved in vesicle membrane fusion, such as VAMP, SNAP-25 (counter part of
SNAP-23 found in skeletal muscle cell) and syntaxin 1a (counterpart of syntaxin 4 found
in muscle cell) in neuron cells by Dr. William W. Winder (Dept. of Physiology and
Developmental Biolgoy, BYU, Provo UT) showed that syntaxin 1a was the only substrate
found for AMPK. Because of the availability of syntaxin 1a and its similarity to syntaxin
4 (the protein of interest; the form of syntaxin expressed in muscle), a study of the
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phosphorylation of syntaxin 1a was performed. The localization of the phosphorylation
site is the first step toward elucidating the role of syntaxin 4 phosphorylation by AMPK
in the glucose uptake mechanism. Elucidation of this mechanism is significant in our
understanding of diabetes mellitus. Activation of AMPK has the same effect as insulin on
glucose uptake. Drugs that activate AMPK in muscle cells will alleviate symptoms of
diabetes patients.

Figure 20. Two mechanisms for stimulation of glucose uptake in skeletal muscle, one
mediated by insulin and one triggered by muscle contraction. The hypothesis of
mediation of the contraction effect by AMPK is based on the observations that exercise
and electrical stimulation increase AMPK activity and glucose uptake and that glucose
uptake is increased by chemical activation of AMPK with AICA-riboside. IR, insulin
receptor; IRS-1, insulin receptor substrate 1; PI 3-kinase, phosphatidylinositol 3-kinase
(Winder et al., 1999).
Through the course of these studies, the need for a positive control
phosphoproteins became evident. Phosducin-like protein (PhLP) was chosen for this role.
PhLP, a protein homologous to phosducin, acts as a co-chaperone for Gβ folding and
assembly of the Gβγ dimer in GPCR signal pathways. In vitro phosphorylation of PhLP
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by CK2 and analysis of its phosphorylation sites has been reported (Lukov et al., 2006).
Here phosphorylated PhLP tryptic peptides served as a positive control for MonoTip®
TiO Pipette Tip enrichment studies.

4.2 MATERIALS AND METHODS
4.2.1 Syntaxin 1a (1a1, 1a7, 1a9, 1a11, 1a12) Expression and Protein Purification
Syntaxin 1a and its different truncated forms of recombinant proteins were
provided by Dr. Woodbury (Department of Physiology and Develop mental Biology,
BYU, Provo, UT), which were prepared as previously reported (Woodbury et al., 2006).
The plasmids of syntaxin 1a and its truncated forms (syntaxin 1a7, 1a8, 1a9, 1a11, 1a12)
were gracious gifts from Dr. Mark K. Bennett (University of California, Berkeley).

4.2.2 PhLP Expression and Purification
The bacterial expression vector pET15b (Novagen, Madison, WI) containing
hPhLP-myc-His construct was from Dr. Willardson’s Lab (Dept. Chemistry and
Biochemistry, Brigham Young Univeristy, Provo, UT). The integrity of all constructs
was confirmed by sequence analysis. The construct was transformed into RbCl2
competent DE3 Escherichia coli by heat shock. The protein was expressed and purified
using a Pro-bond nickel-chelate column (Qiagen, Valencia, CA) as described previously
(Savage et al., 2000). The purified protein was exchanged into 20 mM HEPES, pH 7.2,
150 mM NaCl buffer using an ultrafree centrifuge concentrator (Millipore, Billerica,
MA) and the protein concentration was assayed by the Bradford method. The protein was
stored with 50% glycerol at -20 ° C.
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4.2.3 In vitro Phosphorylation of PhLP, Syntaxin 1a and Syntaxin 4a
PhLP phosphorylation by CK2. A 500 µg amount of purified PhLP was
phosphorylated by CK2 (10 unit/µl, Calbiochem) in 20 mM HEPES, pH 7.5, 100 mM
KCl, 20 mM NaCl, 5 mM MgCl2, 5 mM dithiothreitol, and 1 mM ATP for 1 h at 37°C.
The phosphorylation was confirmed by mobility shift in SDS-PAGE using 12% gels.
Syntaxin 1a and syntaxin 4a phosphorylation by AMPK and LKB1/STRAD/MO25
(AMPKK). On the day of the assay, ATP, AMP and DTT were added to the stock
solution (100 mM Hepes, 200 mM NaCl, 20% glycerol, 2 mM EDTA, and 12.5 mM
MgCl2, pH 7.0) to make a working assay mix of final concentration of 40 mM Hepes, 0.2
mM SAMS, ± 0.2 mM AMP, 80 mM NaCl, 8% glycerol, 0.8 mM EDTA, 0.8 mM DTT,
5 mM MgCl2, and 0.2 mM ATP, pH 7.0. AMPK was phosphorylated by adding
LKB1/STRAD/MO25 (AMPKK), which will then phosphorylate syntaxin 1a or syntaxin
4a. The reaction mixture was incubated for two hours at 30 °C. 32P-labeled ATP was used
instead of ATP to assay the phosphorylation rate of syntaxin 1a by this method.

4.2.4 In-gel Digestion of Syntaxin 1a Containing Gel Bands
Gel bands containing syntaxin 1a were cut out and transterred to 1.5 mL
eppendorf tubes. Then they were equilibrated in 1.5 mL of 50% acetonitrile and 50 mM
ammonium bicarbonate buffer for 30 min at room temperature on a micro mixer. After
aspirating off the buffer, proteins in the gel bands were reduced with 150 µl of 5 mM
DTT, 100 mM ammonium bicarbonate reduction buffer for 30 min at 60° C. After
removing the reduction buffer, the gel bands were cooled to room temperature and the
proteins alkylated by incubating 30 min with 150 µl of 20 mM iodoacetamide, 100 mM
ammonium bicarbonate in the dark. The gel bands were then equilibrated with 1 mL of
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100 mM ammonium bicarbonate again and cut into six smaller pieces. They were
dehydrated with 500 µl 50% acetonitrile and 50 mM ammonium bicarbonate for 30 min
under rotation, then speed vacuumed to dryness. Proteins in the gel pieces then were
digested with trypsin digestion solution (0.02 mg/mL trypsin, 25 mM ammonium
bicarbonate) by gradually adding 10 µl aliquots until they were fully rehydrated and then
covered with an additional 30 µL 25 mM ammonium bicarbonate. They were then
incubated at 37 ° C with motion overnight (16-24 h) in a hybridization oven. The
digestion reaction was quenched by adding 1 µl 88% formic acid followed by sonication
for 20 min. The supernatants were separated from the gel pieces by brief centrifugation
for LC-MS/MS analysis.

4.2.5 Enrichment of Phosphopeptides from Tryptic Peptides
Enrichment of phosphopeptides from tryptic peptides of phosphorylated PhLP
and syntaxin 1a were performed with MonoTip® TiO Pipette Tip (GL Sciences, Tokyo,
Japan) according to the manufacturer’s procedure. Briefly this titanium dioxidecontaining silica monolith was conditioned with an acetonitrile phosphate buffer and
equilibrated with 50% acidic acetonitrile. Tryptic peptides from phosphorylated PhLP
and phosphorylated syntaxin 1a were absorbed to the tip by passing them through the tip
several times. The tip was rinsed with 50% acetonitrile 100 mM KCl buffer and eluted
either with 200 mM phosphate pH 7.0 buffer or 2% aqueous ammonia buffer.

4.2.6 LC-MS/MS Analysis of Tryptic Peptides or Enriched Samples
Samples were analyzed on an Applied Biosystems (Framingham, MA) API Qstar
Pulsar i mass spectrometer with an online LC Packings (Dionex, Sunnyvale, CA)
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UltiMate Plus Capillary LC System. Tryptic digests of each protein sample were run
through a 15 cm x 250-µm-ID column hand-packed with Jupiter C18 10-µm reversedphase resin (Phenomenex, Torrence, CA). An initial gradient of 2.2%/min to a
concentration of 60% acetonitrile in 0.1% formic acid was applied to the column,
followed by a 3.5%/min gradient up to a concentration of 95% organic phase. The HPLC
was controlled by the mass spectrometer software (Analyst, Applied Biosystems) and
incorporated a FamOS autosampler (Dionex, Sunnyvale, CA). The column effluent was
analyzed in information-dependant acquisition (IDA) mode on the mass spectrometer. In
this mode, a survey scan (full MS scan) is performed and then the three most intense
peaks from the survey scan are automatically chosen for fragmentation to obtain MS/MS
spectra, as long as they have not been chosen for fragmentation in the last 2 min (timed
exclusion). Data were collected for m/z 500–2500 over a 55-min interval. The IDA
spectra were reconstructed using the Bio-Analyst software and searched in the Mascot
database with and without an extra 80 Da corresponding to phosphorylation. Molecular
ions of m/z predicted for possible phosphorylation sites were selected as parent ions in
manual selection LC-MS/MS experiments. CID spectra were compared with theoretical
peptide fragments to deduce specific phosphorylation sites.

4.3 RESULTS AND DISSCUSSION
4.3.1 Study of PhLP Phosphorylation with Phosphopeptide Enrichment
Study of the PhLP phosphorylation by casein kinase II has been previously
reported (Lukov et al., 2006). The phosphorylation was confirmed by site-directed
mutagenesis analysis (Lukov et al., 2006). As a positive control for the TiO2 enrichment
method, these phosphorylation sites were analyzed with the enrichment procedure using
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Figure 21. MS/MS spectra of T3 of phosphorylated PhLP by CKII. (A), Tryptic peptides
T3 in triply phosphorylated form from the phosphopeptide enriched sample of 50 µg of
tryptic phosphorylated PhLP. (B), Tryptic peptides T3 in quadruply phosphorylated form
from the same sample.
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the TiO2 pipette tip. One of the phosphopeptides (Trypsin digestion fragment 3, T3) with
quadruply phosphorylated sites was enriched and was chosen for fragmentation by
information-dependent acquisition. The triply phosphorylated form and quadruply
phosphorylated form of this T3 were both detected, as shown in spectra A and B of
Figure 21, respectively. Although there are possibilities of three phosphorylation sites out
of seven possible candidate sites in Figure 21A, phosphorylation of S18, S19 and S25 had
the highiest Mowse Score (82.7) compared with the other two possibilities
(LQYYYSSSEDEDSDHEDKDR, Mowse Score 73.3; LQYYYSSSEDEDSDHEDKDR,
Mowse Score 71.7; underline indicates phosphorylation), which were also observed in
the samples of phosphorylated PhLP tryptic peptides without TiO2 enrichment. The data
show that phosphorylation on S25 with any combination of phosphorylation of two out of
the three consecutive serines could be possible. The quadruply phosphorylated form of
the same tryptic peptide was also observed and fragmented. Although the Mowse Score is
low for the fragmentation (35.0), the combination of phosphorylation of S18-20 and S25
gives the highest Mowse score. In light of observation of the triply phosphorylated form
of the same peptide, it is reasonable to conclude that S25 is the site that is phosphorylated
along with any two or all three phosphorylation sites from the three consecutive serines
(S18-20). In concert with data from the report of Lukov et al. (2006) noting the
observation of singly or doubly phosphorylated form of the same peptide,
phosphorylation of one to four sites among the four serine residues (S18-20, S25) is
suggested, with some sites preferred over others. The MonoTip® TiO Pipette Tip did not
successfully enrich T37 of PhLP (N287SATCHSEDSDLEIDALEGPR; ALEGPR is part
of the myc tag on PhLP C-terminus), which was reported in the same paper (Lukov et al.,
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2006). It seems that MonoTip® TiO Pipette Tip tends to enrich multiply phosphorylated
peptides in preference over singly phosphorylated peptides. The same conclusion was
also drawn in other reports (Kweon et al., 2006).

4.3.2 Study of Syntaxin 1a Phosphorylation
The study of syntaxin 1a phosphorylation instead of syntaxin 4 phosphorylation
was done due to availability of syntaxin 1a and the similarity of these two proteins
(shown in Figure 22). The stoichiometry of phosphorylation of syntaxin 1a by AMPK is
7%, as quantified by a 32P-labled ATP in vitro reaction (W. Winder, unpublished results).
As the first step towards elucidation of syntaxin 1a phosphorylation,
syn1a,

1 MKDRTQELRTAKDSDDDDD---VAVTVDRDRFM-----DEFFEQVEEIRGFIDKIAENVE

syn4a,

1 MRDRTHELRQGDDSSDEEDKERVALVVHPGTARLGSPDEEFFHKVRTIRQTIVKLGNKVQ
* *** ***

** *

*

**

*

***

*

**

* *

*

syn1a,

53 EVKRKHSAILASPNPDEKTKEELEELMSDIKKTANKVRSKLKSIEQSIEQEEGLNRSSAD

syn4a,

61 ELEKQQVTILATPLPEESMKQELQNLRDEIKQLGREIRLQLKAIEPQ-KEEADENYNSVN
*

*** * * *

* **

*

**

*

** **

*

*

*

syn1a,

113 LRIRKTQHSTLSRKFVEVMSEYNATQSDYRERCKGRIQRQLEITGRTTTS-EELEDMLES

syn4a,

120 TRMRKTQHGVLSQQFVELINKCNSMQSEYREKNVERIRRQLKITNAGMVSDEELEQMLDS
* *****

**

***

*

** ***

** *** **

* **** ** *

syn1a,

172 GNPAIFASGIIMDSSISKQALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMID

syn4a,

180 GQSEVFVSNILKDTQVTRQALNEISARHSEIQQLERSIRELHDIFTFLATEVEMQGEMIN
*

* * *

*

*** **

*****

syn1a,

232 RIEYNVEHAVDYVERAVSDTKKAVKYQSKAR

syn4a,

240 RIEKNILSSADYVERGQEHVKTALENQKKAR
*** *

*****

* *

** ******* *

*

** *****

* ***

Table 6.Sequence alignments of syntaxin 4a (syn4a) and syntaxin 1a (syn1a) by Sim
software program (available for free at http://ca.expasy.org/tools/sim-prot.html). 124
Amino acids are identical (or 45.8%) in 271 amino acids overlap as shown by asterix (*).
the enrichment of phosphopeptides by MonoTip® TiO Pipette Tip was carried out. A 7.2
µg amount of syntaxin 1a was phosphorylated in vitro, trypsin digested and
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phosphopeptides were enriched as described above (4.2.5). IDA acquisition was used to
collect tandem MS spectra. No phosphopeptide candidates were chosen for
fragmentation. With the experience of analysis of phosphorylated PhLP, single
phosphorylation of peptides might be one of the reasons that no candidates were chosen
for fragmentation here. Phosphorylation stoichiometries below 20% pose a challenge to
the identification of phosphorylation sites.
As a result, a second approach was applied. This approach involved the
mapping of possible phosphorylation candidates by taking advantage of the posttranslational modification mapping program provided with the Analyst software. False
positives were ruled out by employing several criteria [including: existence of the
unphosphorylated form (in the case of low phosphorylation rate), peptide/phosphopeptide
retention time on reverse-phased liquid chromatography and non-specific noise by
comparing with controls] and then, chosen candidates (of specific m/z) were fragmented
by manual selection LC MS/MS for confirmation. In this case, phosphorylated syntaxin
1a and controls (from reactions without LKB1/STRAD/MO25, the AMPKK) were run on
an SDS-PAGE gel in order to purify the samples (Table 7). Samples from in-gel
digestion of four lanes (two samples and two controls) were run on the Qstar MS as
described (materials and methods section) using the IDA acquisition mode. Mapping
modification was carried out on all four samples. Only tryptic peptide number 32 (T32,
T159TTSEELEDMLESGNPAIFASGIIMDSSISK189) of syntaxin 1a was identified as a
phosphopeptide found after ruling-out false positives.
The unphosphorylated form of T32 (m/z=1092.4967 of average mass, +3 charge,
retention time between 21.0-22.0 minute) was found among all four samples. But the

93

phosphorylated form of T32 (m/z=1119.2 of average mass, +3, tR =21.0-21.7min) was
only found in the two samples, not in controls, as shown in ion extraction (XIC) of ions
with m/z between 1118.7 and 1119.7 (Figure 22).With the availability of the several
truncated forms of syntaxin 1a, experiments were designed to narrow down the possible

Figure 22. Ion extractions of m/z (1118.7-1119.7) of TOF MS experiments from
syntaxin 1a phosphorylation samples and controls. The phosphorylated form of T32 of
syntaxin 1a is eluted between 21.0-21.7 min. The two samples (Lane 1 and Lane 2) were
added with strain 8 phosphorylated AMPK and the two controls (Lane 3 and Lane 4)
were without strain 8 phosphorylated AMPK.
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Lane
Cocktail Buffer with ATP,
DTT, AMP

1

2

3

4

10

10

10

10

Syn1A1 (100 µg/mL)

5

5

5

5

Strain 8 phosphorylated AMPK

2

2

0

0

Water
8
8
8
8
Incubation time
2h
2h
2h
2h
Table 7. In vitro phosphorylation of syntaxin 1a for in-gel digestion. All volume units are
in µL.

Figure 23. Autoradiography of in vitro phosphorylated synatxin 1a and its truncated
forms by actvivated AMPK. (A) The film was incuabated about four hours. (B) The film
was developed overnight for the same region from the dye front to 25 KDa molecular
maker. Sequnces of syntaxin 1a1, 1a7, 1a8, 1a9, 1a11, and 1a12 are 1-288, 8-288, 77288, 115-288, 194-288, and 221-288, respectively.
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phosphorylation sites by their in vitro phosphorylation with 32P-labeled ATP to roughly
verify the mapping result.
The different truncated forms (about 0.2 µg of each, with the exception of
syntaxin 1a7 with a lower amount) of syntaxin 1a were in vitro phosphorylated as was
syntaxin 1a, shown in Table 7. In this experiment syntaxin 1a, syntaxin 1a1, syntaxin
1a7, syntaxin 1a8, and syntaxin 1a9 were phosphorylated while syntaxin 1a11 and
syntaxin 1a12 were not. With the sequences of truncated forms of syntaxin 1a (listed in
the caption of Figure 23), we can conclude that the phosphorylation site(s) should be
between amino acids 115-193, which is consistent with peptide T32159-189 suggested by
mass spectrometry. The fragmentation of phosphorylated T32 was not successful due to

Figure 24. MS/MS spectrum of unphosphorylated T32 (1637.7, +2,) with strong b, y ions
labeled.
its extremely low signal intensity. Its unphosphorylated form, however, was successfully
fragmented and its sequence was confirmed as shown in Figure 24 (with a Mowse Score
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of 66). The +2 charged form of phosphorylated T32 was also found in the phosphorylated
samples. Despite this accumulated evidence that T32 is a phosphopeptide, the exact
phosphorylation site remains unknown. Site-directed mutagenesis of potential
phosphorylation sites would be necessary to pinpoint the exact sites, which would also
serve as in vivo verification. It would be wise to start with highly likely sites such as
S162, S186, S188, T160 and T161 (predicted by Netphos 2.0). With the observation of
S188 minus water in the fragmentation of unphosphorylated T32, S188 might be the first
choice for a site-directed mutagenesis study.

Figure 25. MS/MS spectrum of T12 of syntaxin 4a (1012.5, +2, Mowse score, 20) with
strong b, y and their de-ammonia (b*) form labeled.
With the surprise finding of the difference in syntaxin 1 and syntaxin 4
phosphorylation by PKA (cAMP-dependent protein kinase), it is necessary to study
syntaxin 4 phosphorylation by AMPK. Above all, this is because it is syntaxin 4 that is
present in the muscle cells, and thus, more relevant to the physiology of interest. Pure
syntaxin 4a (amino acid sequence, 1-273, without the membrane spanning region,
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residues 274-293) was purchased (Synaptic system, Goettingen, Germany) and in vitro
phosphorylated in the same manner as syntaxin 1a. A candidate for the phosphorylated
peptide T12 (Q65QVTILATPLPEESMK80) was chosen for fragmentation in the IDA
mode. Three possible phosphorylation sites (T68, T72 and S78) were identified based on
the fragmentation (Figure 25). The Mowse score was 20, which means further
verification of these sites will be needed by site-directed mutagenesis or other methods.
Site-directed mutagenesis will also be needed for in vivo confirmation of phosphorylation
and study of the role of this phosphorylation.

4.4 CONCLUSIONS
Different strategies were applied for different cases of protein phosphorylation
analysis. Although PhLP phosphorylation by CK2 has been previously studied, more
detailed characterization of its multiply phosphorylated peptide was enabled after it had
been enriched using the MonoTip® TiO Pipette Tip. All four serine phosphorylation sites
in the peptide were identified with high confidence by MS. Analysis of syntaxin 1a
phosphorylation was very difficult due to the low phosphorylation stoichiometry.
Enrichment by MonoTip® TiO Pipette Tip was unsuccessful. Taking one step back,
peptide level mapping for phosphorylation of syntaxin 1a was carried out. Some general
rules for phosphopeptide mapping are 1) the non-phosphopeptide form should always be
observed when the phosphorylation rate is low, 2) clean samples should be used to reduce
false positives and a control with a phosphatase would be recommended, and 3) retention
time can also be used to rule out false positives. Increased polarity from the phosphate
group leads to shorter retention time on reverse-phased LC. Only one peptide,T32, was
identified as a potential phosphopeptide under these rules. Further work such as site-
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directed mutagenesis will be required in order to pinpoint the exact phosphorylation
location. Analysis of phosphorylation of the more relevant protein syntaxin 4 by AMPK
seemed to be more successful than analysis of syntaxin 1a. Three phosphorylation sites
((T68, T72 and S78) were suggested on the same peptide by IDA acquisition with a
Mowse score of 20. The good fragmentation of its unphosphorylated form gives more
confidence to the possible identification of these phosphorylation sites. Still, further
confirmation will be required. The next step will be the study of the role of this
phosphorylation in AMPK activation and glucose uptake.

4.5 REFERENCES
Goodyear, L. J., and B. B. Kahn. (1998) Exercise, glucose transport, and insulin
sensitivity. Annu. Rev. Med. 49: 235–261
Hayashi, T., J. F. P. Wojtaszewski, and L. J. Goodyear. (1997) Exercise regulation of
glucose transport in skeletal muscle. Am. J. Physiol. 273 (Endocrinol. Metab. 36):
E1039–E1051,
Hayashi, T., M. F. Hirshman, E. J. Kurth,W.W.Winder, and L. J. Goodyear. (1998)
Evidence for 58-AMP-activated protein kinase mediation of the effect of muscle
contraction on glucose transport. Diabetes 47: 1369–1373
Holloszy, J. O., and P. A. Hansen. (1996) Regulation of glucose transport into skeletal
muscle. Rev. Physiol. Biochem. Pharmacol. 128: 99–193
Kweon HK, Hakansson K. (2006) Selective zirconium dioxide-based enrichment of
phosphorylated peptides for mass spectrometric analysis. Anal Chem. 78:1743-9
Lazarov, M. E., Martin, M. M., Willardson, B. M. & Elton, T. S. (2000) Molecular
cloning and characterization of the human phosducin-like protein promoter.
Biochimica et Biophysica Acta 1492, 460–464
Lukov GL, Baker CM, Ludtke PJ, Hu T, Carter MD, Hackett RA, Thulin CD, Willardson
BM. (2006) Mechanism of assembly of G protein betagamma subunits by protein
kinase CK2-phosphorylated phosducin-like protein and the cytosolic chaperonin
complex. J Biol Chem. 281:22261-74.
Savage JR, McLaughlin JN, Skiba NP, Ha HE, Willardson BM. (2000). Functional roles
of the two domains of phosducin and phosducin-like protein. J Biol Chem 275,
30399–407.
Vavvas, D., A. Apazidis, A. K. Saha, J. Gamble, A. Patel, B. E. Kemp, L. A.Witters, and
N. B. (1997) Ruderman. Contractioninduced changes in acetyl-CoA carboxylase
and 58-AMP-activated kinase in skeletal muscle. J. Biol. Chem. 272: 13256–
13261

99

Winder WW, Hardie DG. (1999) AMP-activated protein kinase, a metabolic master
switch: possible roles in type 2 diabetes. Am J Physiol. Jul;277(1 Pt 1):E1-10.
Winder, W. W., and D. G. Hardie. (1996) Inactivation of acetyl-CoA carboxylase and
activation of AMP-activated protein kinase in muscle during exercise. Am. J.
Physiol. 270 (Endocrinol. Metab. 33): E299–E304
Woodbury , D. J., J. M. McNally, J. R. Lemos. (2006) SNARE-induced fusion of
vesicles to a Planar Bilayer. Chapter 10 in "Advances in planar lipid bilayers and
liposomes", edited by A. Leitmannova-Liu. (Elsevier) Vol. 5:287-313. (in press).

100

CHAPTER FIVE

FUTURE WORK
Future work involves finishing up the incomplete part of syntaxin 4
phosphorylation by AMPK and its role in the signal pathway, as well as synthesizing a
more hydrophilic monomer, such as acrylamidomethanesulfonic acid, for the monolithic
SCX column to achieve a less hydrophobic property.

5.1 APPLIED SITE-DIRECTED MUTAGENESIS TO CONFIRM THE
IDENTIFIED PHOSPHORYLATION SITES IN VIVO AND ROLES OF
PHOSPHORYLATION ON THESE SITES
5.1.1 Confirmation of the Identified Phosphorylation Sites in vivo
Confirmation of these possible phosphorylation sites in vivo can be done in three
steps. First, plasmids containing the desired mutation of syntaxin 4 and a tag (such as
myc tag) can be transfected to a rat cell line. Cells will be serum starved and then
incubated with serum and radio label (32P-labeled phosphate). Immunoprecipitation with
an antibody against the tag will be performed to pull down syntaxin 4 mutants. No
radioactivity should be detected if the mutation on these identified sites successfully
blocks the phosphorylation. Otherwise, phosphorylation site(s) other than the identified
could be phosphorylated.

5.1.2 Role of Phosphorylation on the Identified Sites
After the phosphorylation sites are confirmed in vivo, study of the role of this
phosphorylation in the process of AMPK activation and glucose uptake will be carried
out. According to the proposed mechanism, phosphorylation potentially increases the
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vesicle-membrane fusion process. If it is true, mutation of these sites should block the
process. The role of this phosphorylation in the fusion process can be deduced by the
degree that the fusion process is blocked by mutation of these sites.

5.1.3 Examination of the Possibility of other SNARE Proteins Involved in This
Vesicle-membrane Fusion Process
Although Dr. Winder has ruled out the possibility of SNAP-25 and VAMP
protein phosphorylation by AMPK, it is possible that their counterparts SNAP-23 and
VAMP-2 might behave differently as substrates for AMPK, especially when considering
that syntaxin 1a and syntaxin 4a are phosphorylated differently by AMPK. Initial
examination can be done by using recombinant SNAP-23 and VAMP-2 proteins in vitro
phosphorylated by AMPK. Further experiments will be carried out if there is any sign of
phosphorylation of these proteins in vitro. It is not hard to tell if they can be
phosphorylated or not with the 32P-labeled in vitro phosphorylation experiment.

5.2 FUTURE WORK ON THE MONOLITHIC SCX COLUMN
Either the synthesis of acrylamidomethanesulfonic acid through new approaches
or the separation of acrylamidomethanesulfonic acid from 2-aminoethansulfonic acid will
be recommended for future work to achieve a more hydrophilic monomer for the
monolithic SCX column.
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